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Abstract 
Wnt signalling is active both in development and the progression of certain disease 
processes, most notably cancer. Glycogen Synthase Kinase-3 (GSK-3) and ß-catenin both 
define the canonical Wnt pathway, where GSK-3 negatively regulates ß-catenin, which, in 
turn, regulates gene expression. Mutations to ß-catenin that prevent GSK-3 phosphorylation 
are associated with the progression of many different tumour types. In addition to its 
signalling function, ß-catenin is required structurally at adherens junctions, linking cadherin 
molecules to the actin cytoskeleton via its interaction with a-catenin. Loss of 1-catenin 
from adherens junctions is associated with the increased invasiveness and metastasis of 
tumour cells. 
Homologues of GSK-3 (GskA) and ß-catenin (Aardvark) have been cloned in the cellular 
slime mould Dictyostelium discoideum. Aardvark is required for both the expression of the 
pre-sprore marker gene pspA and the formation of adherens junctions in Dictyostelium. 
This thesis describes the characterisation of Aardvark, with particular regard to its function 
and interaction with GskA. 
This work shows that distinct regions of Aar are required for its signalling and adhesion 
functions and suggests that two distinct proteins may bind to it to mediate the formation of 
adherens junctions. A novel protein kinase has been identified that may phosphorylate the 
N-terminus of Aar to regulate the expression of the pre-spore marker gene pspA. Full- 
length Aar is unstable and a `destabilisation' region has been identified within the core of 
the protein. A novel derepression mechanism is used to explain GskA and Aar function in 
the expression of pspA. The characterisation of non-canonical Wnt signalling will enhance 
the understanding of the evolution and function of the core components of the pathway, 
giving greater insight into their roles in both development and disease processes. 
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1.1 Introduction 
1.1.1 Genes, development and disease 
The human genome contains 30,000-40,000 protein-coding genes (Lander et at., 2001). It is 
the differential expression of these genes that underlies the differences in cell types seen in 
an adult human. Gene expression controls both growth and development to produce a new- 
born baby from a fertilised egg. This growth and differentiation also needs to be coupled 
with morphogenesis; that is, the movement of cells into the required pattern to determine 
the correct final body plan. During morphogenesis, cells must communicate with one 
another (cell signalling) and also stick to one another (cell-cell adhesion). It is this coupling 
of growth and differentiation with morphogenesis that defines `development'. Defects in 
development can often lead to the onset of disease process; cancer being a common 
example. Both cell signalling and cell adhesion processes are active in cancer. These cells 
continuously perceive the signal to grow and divide, with the reduced adhesion of cells 
leading to the metastasis of tumours. 
1.1.2 The Wnt Pathway 
One of the major pathways contributing to both development and cancer is the Wnt 
pathway. Genetic experiments in the fruit fly, Drosophila melanogaster, gave the first 
glimpse of the pathway. The Wingless protein (Wg) controls cell fate; for example, 
instructing cells of the wing that they should be posterior cells. Later, Int-1 was shown to 
be the human homologue of Wg, and the amalgamation of the two names produced the 
name `Wnt'. The pathway has since been shown to control many developmental processes 
- including cell fate specification, embryonic axis formation, and cell proliferation - across 
a wide spectrum of vertebrate and invertebrate organisms (Cadigan and Nusse, 1997; Moon 
et al., 1997). Mutations to many of the genes of this pathway have been shown to be 
coincidental with a large number of tumour types (Polakis, 2000). 
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Signals mediated by Wnt ligands have been shown to branch into four intracellular 
pathways: (1) a canonical Writ pathway, which signals through TCF/LEF-1 transcription 
factors via GSK-3 and ß-catenin (see Cadigan and Nusse, 1997); (2) a planar cell polarity 
pathway, which utilises Rho-kinase and JNK to cause cytoskeletal rearrangements (see 
Sokol, 2000); (3) a Wnt/Ca2+ pathway that controls PKC and CamKII to regulate cell 
adhesion and motility (see Kuhl et al., 2000); and (4) a novel pathway that regulates spindle 
orientation and asymmetric cell division, through GSK-3 and APC (see Huelsken and 
Birchmeier, 2001). Whilst Wnt is common to all of these pathways, many of the other 
components differ greatly. Dishevelled is a protein that may act as the switch between the 
different pathways (figure 1.1). 
Wnt signalling via the canonical pathway requires the accumulation of (3-catenin within the 
cell. ß-catenin complexes with HMG-box transcription factors of the TCF/LEF-1 family to 
induce expression of downstream genes (Huber et al., 1996b). However, (3-catenin is 
normally targeted for breakdown via the proteasome, following phosphorylation by a 
complex containing Axin, APC, GSK-3 and Casein Kinase 1. The Wnt signal inhibits 
GSK-3, via a process that is known to require Dishevelled. 
1.1.3 ß-catenin and GSK-3: central components of the Canonical Wnt Pathway 
Canonical Wnt signalling in cancer is typified by tumorigenesis in the epithelial lining of 
the colon. Wnt regulates cell proliferation. A critical balance exists between the rate of 
proliferation and the rate of death of cells due to attrition. Mutations to single components 
of the pathway can tip the balance in the favour of proliferation, with unregulated division 
leading to the onset of carcinogenesis. 
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Figure 1.1 Wnt signalling diversifies into at least 4 branches 
Writ signalling via Dishevelled has been shown to regulate both canonical Writ signalling 
and planar cell polarity. Recent evidence suggests that PLC activation by Wnt signalling in 
the Ca 2+ pathway may involve G-proteins, whilst a pathway utilising GSK-3 and APC has 
been shown to regulate asymmetric cell division in C. elegans. Figure adapted from 
Polakis, 2001. 
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(3-catenin plays a vital role in both the proliferation of epithelial cells and the metastasis of 
tumours. It is required in a signalling capacity, as a downstream effector of Wnt. It is also a 
major component of the adherens junctions. These junctions connect cells in a single 
epithelial sheet by interconnecting the actin filaments of adjacent cells and forming a tight 
belt between them. The mis-regulation of ß-catenin, either through mutation to the protein 
itself, or its regulatory protein APC (Adenomatous Polyposis Coli), is found associated 
with over 80% of inherited and sporadic colon carcinomas (Polakis, 2000). In addition to 
the mis-regulation of 1-catenin signalling, loss of the protein from the adherens junctions 
reduces adhesion and leads to increased metastasis of tumours (Kawanishi et al., 1995). 
GSK-3 is absolutely required for ß-catenin regulation. Phosphorylation by GSK-3 leads to 
the ubiquitin-dependent proteasomal degradation of (3-catenin. 
Genetic studies in the mouse Mus musculus, and Drosophila, as well as cell biological and 
biochemical studies in cultured mammalian cells and the frog Xenopus laevis, established 
the canonical pathway. More recently, components of the pathway have been found in 
hydra (Hobmayer et al., 2000) and the cellular slime mould Dictyostelium discoideum 
(Grimson et al., 2000; Harwood et al., 1995). Dictyostelium exist as free-living amoebae, 
but following starvation form a multicellular fruiting body composed primarily of two cell 
types: stalk and spore. This morphogenesis requires Dictyostelium to undergo 
differentiation, along with regulated cell-cell adhesion, in a process which requires at least 
two Wnt pathway homologues (see Coates and Harwood, 2001). Like mammalian cells, a 
(3-catenin homologue, Aardvark, is required for cell signalling and the formation of 
adherens junctions in Dictyostelium (Grimson et al., 2000). The further characterisation of 
Aar is described in this thesis. 
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1.2 Wnt ligands and receptors 
1.2.1 Wnts 
In 1982, Roel Nusse and Harold Varmus discovered that int-1 (later renamed Wnt-1 due to 
its homology with the Drosophila protein Wingless) was responsible for the majority of 
tumours in mice infected with the mouse mammary tumour virus (Nusse and Varmus, 
1982). To date, 18 human and four Drosophila Writ genes have been identified (Huelsken 
and Birchmeier, 2001). Writs are cysteine-rich secreted proteins that act as intercellular 
signalling molecules. Purification is made difficult by the high level of hydrophobicity and 
the formation of aggregates by secreted Writs. 
1.2.2 Frizzleds and LRPs 
For many years the inability to purify Wnt proteins made identification of their cognate 
receptors difficult. More recently, genetic, cell biological and biochemical approaches have 
suggested that the frizzled (Fz) cell-surface receptors act as receptors for Wnt proteins. 
Fzs are seven-pass transmembrane proteins. They contain a putative N-terminal signal 
sequence, and C-terminal to this is a sequence of 120 amino acids, which contains 10 
highly conserved cysteine residues. A highly divergent region of 40-100 amino acids are 
predicted to form a flexible linker and seven transmembrane segments are separated by 
short extracellular and cytoplasmic loops before the protein ends with a C-terminal 
cytoplasmic tail (Wang et al., 1996). 
The overall structure of Fzs resembles that of G-protein coupled receptors (GPCRs), but 
whether Wnt signalling proceeds via G-proteins remains controversial. Little evidence 
exists, but one group has recently tried to answer this question using a chimaeric receptor 
with the ligand-binding and transmembrane segments from the 32-adrenergic receptor 
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((32AR) and the cytoplasmic domains from rat Frizzled-1 (Rfz 1) (Liu et al., 2001 b). They 
show that treatment with the (3-adrenergic agonist isoproterenol leads to the stabilisation of 
(3-catenin in mouse cells transformed with the chimaeric receptor. Furthermore, G-protein 
inactivation or depletion of Gaq and Gao blocked the response. 
Ten human and four Drosophila Fzs have been identified to date. The first mutation in afz 
(fzl) was discovered by genetic screens in Drosophila and exhibits a tissue polarity defect 
(Vinson and Adler, 1987). The epithelial cells that make up the wing blade are usually 
aligned such that the single hairs on each cell all point in a distal direction (Adler, 1992). In 
fzl mutants, hairs point in every direction. In addition, fzl mutants display a mis-orientation 
of the ommatidia comprising the compound eye (Zheng et al., 1995), something which is 
also seen with mutants of Dsh, a protein which is required for transduction of the Wg signal 
- see section 1.3 (Theisen et at., 1994). The endogenous ligand of Fz1 has not been 
established, however the role of Dsh suggested that the Fz family may transduce Wnt 
signals. 
Subsequent analysis showed that the fz-related gene in Drosophila, Dfz2 is a Wg receptor. 
Stable transfection of Dfz2 into cell lines in which it would not normally be expressed, turn 
them from Wg non-responsive to Wg-responsive (Bhanot et al., 1996). Wg protein, 
however, does not bind uniquely to Dfz2, and in fact will also bind the original Fz. Some 
redundancy appears to exist between the Fz receptors, but the identification of a Wnt co- 
receptor has shed more light onto the subject. 
LRP5 and LRP6 (arrow in Drosophila), members of the low-density lipoprotein-related 
proteins (LRPs), are coreceptors of Wnt. Arrow is essential for the transduction of 
Wingless in Drosophila (Wehrli et al., 2000), whilst LRP6 is essential for Wnt transduction 
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in Xenopus, and the extracellular domain of LRP6 has been shown to interact with Frizzled 
in a Wnt-dependent manner (Tamai et al., 2000). The intracellular domain of LRP5 binds 
Axin, and this is enhanced by the addition of Wnt (Mao et al., 2001). In addition, binding to 
LRP5 induces degradation of Axin, which can trigger LEF-1-mediated gene transcription. 
1.2.3 Wnt antagonists 
Several classes of protein have been discovered that will block Wnt signalling at the cell 
surface. They do this by directly binding Wnt proteins, or by competing for binding with 
either the Fz receptors, or the LRP receptors. 
Wnt-inhibitory factor-1 (WIF-1) is a secretory protein that binds Writs and inhibits their 
function; presumably by preventing them from binding to the Fz receptors (Hsieh et al., 
1999). Highly conserved orthologues are found in mice, Xenopus and zebrafish. 
Cerberus encodes a secreted protein that is expressed in the anterior endomesoderm of 
Xenopus (Bouwmeester et at., 1996). Cerberus has been shown to directly bind XWnt8, 
with microinjection of cerberus mRNA into Xenopus embryos inducing ectopic heads. 
Independent of Wnt binding, Cerberus also possesses two further sites required for nodal- 
related and bone morphogenic protein (BMP) signalling - two pathways required for head 
formation in Xenopus. A murine homologue, mCer-1, has also been isolated (Biben et at., 
1998). 
sFRPs (secreted frizzled-related proteins) are a family of secreted proteins, all 
approximately 30kDa in size, which contain a cysteine-rich domain (CRD) similar to that 
of Fzs. C-terminal to the CRD is a stretch of charged residues with homology to nectrins; a 
family of secreted proteins involved in axon guidance (Finch et al., 1997; Rattner et al., 
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1997). The first sFRP to be cloned, Frizzled in bone, Fzb (also known as sFRP-3) was 
discovered in rats, where it is required for skeletal development (Hoang et al., 1996). sFRPs 
have been shown to bind Wg and inhibit downstream signalling, with the CRD both 
necessary and sufficient for this (Wang et al., 1997; Xu et al., 1998). More recently, 
evidence of an activating role for sFRP-1 in Wg signalling has been shown (Uren et al., 
2000), raising the possibility that these proteins may act as inhibitors or activators of Wg 
signalling, depending on their cellular context. 
Dikkopf-1 (Dkk-1), the first Dkk to be discovered (four have been found to date), was 
isolated as a secreted protein that induces the Spemann's organiser (an embryonic region 
with potent head-inducing activity) in Xenopus (Glinka et al., 1998). Injection of mRNA 
showed that Dkk-1 is both necessary and sufficient to cause head induction in Xenopus. 
Dkks are composed of two CRDs separated by a spacer region of variable length. The 
domains are well conserved across all four Dkk family members (Krupnik et al., 1999). 
Both Dkk-1 and Dkk-2 have been shown to interact with the Fz co-receptor LRP6/Arrow to 
antagonise Wg signalling (Bafico et al., 2001; Glinka et al., 1998; Li et al., 2002); 
presumably, by competing for binding with Wg. This interaction occurs in a Dsh- 
independent manner. Dkk-4 is also a Wg antagonist, but there is no evidence that Dkk-3 
modulates Wnt signalling. 
The individual domains of Dkk-1 and Dkk-2 possess distinct functional activities. Both 
1't pit 
Dkks ! D*f Wnt8 and cooperate in the induction of head structures, but only Dkk-2 
synergises with the Wnt co-receptor LRP6 to activate 0-catenin signalling (Brott and Sokol, 
2002). These differences have been attributed to variations in the N-terminal domains of the 
proteins. 
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1.3 Dishevelled 
1.3.1 Dishevelled and the Canonical Wnt Pathway 
The dishevelled gene (dsh) of Drosophila encodes a cytoplasmic phosphoprotein with no 
known biochemical function. Genetic epistasis experiments placed Dsh downstream of Wg 
and upstream of Zw-3 (figure 1.1). 
Dsh becomes hyperphosphorylated following Wg stimulation and this form of the protein is 
found enriched at the plasma membrane (Yanagawa et al., 1995). This suggests that Wg 
signalling recruits Dsh to the membrane. Casein Kinase 2 (CK2) has been implicated as the 
kinase which phosphorylates Dsh, following the discovery that Dsh is found in a complex 
with CK2 and CK2 will phosphorylate Dsh at high levels in vitro (Willert et al., 1997). The 
CK2 inhibitor apigenin blocks proliferation in Wnt-1 transfected cell lines, abolishes ß- 
catenin phosphorylation, and reduces ß-catenin and Dvl (the mammalian homologue of 
Dsh) protein levels (Song et al., 2000). This implies that both Dsh and CK2 are part of the 
Wg signalling pathway and both are positive regulators of the signal. However, over- 
expression of one of the Wg receptors, Dfz2, leads to phosphorylation of Dsh, but not 
accumulation of the ß-catenin homologue Armadillo (Arm) (Willert et al., 1997). Therefore 
Dsh phosphorylation is insufficient for the transduction of the Wg signal to Arm. 
Dsh has highly conserved homologues in Xenopus and mice. Over-expression of Dsh in 
Drosophila and Xenopus can mimic Wnt signalling, (Rothbacher et al., 1995; Yanagawa et 
al., 1995), but a knockout of the dsh homologue dvll in mice fails to display any of the 
drastic Wnt phenotypes (Lijam et al., 1997). However, this may reflect a redundancy 
amongst the 3 mice homologues of Dsh (Dvll/2/3). 
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At least three conserved domains have been identified in Dsh, the N-terminal DIX 
(dishevelled, axin interaction) domain, a central PDZ (Postsynaptic density 95, discs large, 
zonula occludens-1) domain and a C-terminal DEP (dishevelled, 1-10, Pleckstrin 
homology) domain (Boutros and Mlodzik, 1999). The DIX domain binds to the C-terminus 
of Axin, which also possesses a DIX domain, whilst the PDZ domain appears to bind Frati 
(frequently rearranged in advanced T-cell lymphomas 1), one of the two human 
homologues of GBP (GSK-3 binding protein) (Li et al., 1999). The DEP domain is required 
for planar cell polarity (see below), but not Wg signalling (Axelrod et al., 1998). This 
supports the idea that Dsh may act as the switch between Fz-mediated cell fate and Fz- 
mediated planar cell polarity. 
1.3.2 Dishevelled and planar cell polarity 
Epithelial cells are polarised in two ways. Apical-basal polarity distinguishes the top and 
bottom surfaces of the epithelial sheet, and planar polarity allows cells to determine 
directions in the plane of the sheet. Wnt signalling regulates planar cell polarity (or PCP). 
Each of the hexagonal cells that comprise the Drosophila wing secrete a single hair, an 
actin-rich plasma membrane projection. Each and every one of the hairs points distally 
from the distal cell vertex. Mutations, which disrupt PCP, orientate the polymerised actin in 
random locations, and hence the hairs point in all directions. 
A non-canonical Wnt pathway appears to control PCP (Boutros and Mlodzik, 1999). 
Genetic epistasis experiments have suggested the involvement of the small GTPase RhoA 
and c-Jun NH2-terminal kinase (JNK) downstream of Fz in the PCP pathway. Dsh can 
activate JNK (Boutros et al., 1998), suggesting that Dsh may act at the branch point 
between Wnt-mediated cell fate and Wnt-mediated PCP. In addition, Axin has been shown 
to interact with MEKK1, dimerising to activate JNK signalling (Zhang et al., 1999). The 
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involvement of both Dsh and Axin raises the possibility that an interaction between the two 
may be required for Dsh-mediated control of PCP. 
1.3.3 Dishevelled and Notch 
Mutations in presenilin (PS) genes are associated with Alzheimer's disease (see De Ferrari 
and Inestrosa, 2000). PS proteins mediate cleavage of the C-terminal domain of Notch. 
Notch subsequently enters the nucleus to regulate transcription. Genetic epistasis 
experiments have suggested that Dsh interacts antagonistically with Notch and Dsh has 
been shown to bind the cytoplasmic tail of Notch in a yeast two-hybrid system (Axelrod et 
al., 1996). 
1.4 ß-catenin and TCF/LEF-1 
Along with GSK-3, these two proteins define the canonical Wnt pathway. It is the 
interaction of (3-catenin with HMG-box transcription factors of the TCF/LEF-1 family that 
leads to the activation of Wnt target genes such as cyclin D and c-myc (Huber et al., 
1996b). Co-expression of ß-catenin and these transcription factors leads to the 
accumulation of ß-catenin in the nucleus. Mutations to Pangolin (Pan) - the Drosophila 
LEF homologue - that block binding to Armadillo, reduce Wg signalling in vivo (Brunner 
et al., 1997). In Xenopus, injection of RNA encoding a mutant form of XTcf-3 (the LEF-1 
homologue) that cannot bind f3-catenin acts as a dominant negative (Molenaar et al., 1996). 
This, along with the finding that ß-catenin accumulates in the nucleus upon Wnt 
stimulation, led to the idea that Wnts induce the accumulation of a ß-catenin/TCF complex 
in the nucleus (Huber et al., 1996a). Further extrapolation of these findings led to the 
hypothesis that the ß-catenin/TCF complex acts as a composite transcription factor, where 
TCF provides the site-specific DNA binding and ß-catenin activates the transcription of 
target genes bound by the complex (van de Wetering et al., 1997). 
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In addition to ß-catenin, a second protein, Pygopus (Pygo), that is required for TCF- 
mediated transcription has recently been discovered in Drosophila; and possesses two 
homologues in humans and one in Xenopus (Belenkaya et al., 2002; Kramps et al., 2002; 
Parker et al., 2002; Thompson et al., 2002). Mutations to Pygo carry the Wg phenotype, 
and the protein is required for TCF-mediated transcription but not the stabilisation of ß- 
catenin. Pygo is a nuclear protein that is found complexed with the ß-catenin homologue 
Armadillo, in Drosophila. The amino acid sequence identifies a PHD domain, suggesting a 
function in chromatin remodelling. In addition, the Drosophila BCL9 homologue Legless 
(Lgs) appears to be required for the recruitment of Pygo to the 0-catenin-TCF complex 
(Kramps et al., 2002). An alternative hypothesis to the widely-accepted ß-catenin/TCF 
transcription factor model has recently emerged (Chan and Struhl, 2002). This new model 
suggests that ß-catenin may transduce Wnt signals by exporting TCF from the nucleus or 
by activating it in the cytoplasm. 
In the absence of a Wnt signal, ß-catenin is phosphorylated in a complex with Axin, GSK- 
3, CKW and APC. Mutations at four Ser and Thr residues in the N-terminus of ß-catenin, 
are prevalent in several types of human carcinoma (Korinek et al., 1997; Morin et al., 1997; 
Rubinfeld et at., 1997). It is the phosphorylation of Ser-33 and Ser-37 by GSK-3 that 
targets ß-catenin for ubiquitination, facilitating the binding of the F-box protein 3Trcp, and 
leading to proteosome-mediated degradation (Orford et al., 1997; Aberle et al., 1997; Liu et 
at., 1999). 
The Dropsohila gene slimb, which contains and F-box and WD-40 repeats, negatively 
regulates Wg signalling (Jiang and Struhl, 1998). Proteins containing F-boxes are thought 
to serve as adaptor molecules, with the F-box binding to the E3 ubiquitin ligase. Studies in 
Xenopus revealed that the F-box/WD40-repeat protein ß-Trcp bridges phosphorylated ß- 
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catenin and the E3 ubiquitin ligase Skpl, targeting it for breakdown via the proteasome 
(Liu et al., 1999). 
More recently, Siah-1, the human homologue of Drosophila seven in absentia has been 
shown to mediate a novel ß-catenin degradation pathway (Liu et al., 2001a). Siah proteins 
have a short half-life and are normally kept at a low level within the cell (Hu and Fearon, 
1999). Activation of the tumour suppressor protein p53 is thought to stabilise Siah-1. 
Breakdown of ß-catenin following p53 activation has previously been reported (Sadot et 
al., 2001). Siah-1 binds the C-terminus of APC and a second protein SIP which, like 3Trcp, 
is able to bind Skpl, along with the F-box protein Ebi (Matsuzawa and Reed, 2001). Ebi is 
able to bind to (3-catenin, in a non phosphorylation-dependent manner and APC binds to 
both Siah-1 and ß-catenin, bridging the two (Matsuzawa and Reed, 2001). Figure 1.2 
highlights these two ß-catenin degradation pathways. 
This proposes a two-tiered mechanism for the destruction of ß-catenin. In the canonical 
Wnt Pathway, ß-catenin is targeted for breakdown following phosphorylation within the N- 
terminus and the binding of the F-box protein (3-Trcp. Mutations to the phosphate-accepting 
residues in the N-terminus of ß-catenin are only associated with a small number of 
incidences of colon cancer. This low incidence could be explained by the discovery of this 
second, p53-mediated, ß-catenin degradation pathway. Forms of ß-catenin which have 
escaped recognition by (3Trcp become bound by the F-box protein Ebi, again at the N- 
terminus, in a non-phosphorylation-dependent manner (for a review of both (3Trcp and Ebi- 
mediated ß-catenin degradation, see Polakis, 2001). 
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Figure 1.2 Protein interactions in the degradation of ß-catenin 
R= ring domain, F= F-box, MCR = mutation cluster region. See text for details. 
1.5 GSK-3 
The Zeste-White-3/Shaggy (Zw3/Shg) serine/threonine protein kinase of Drosophila 
possesses two highly homologous mammalian paralogues, glycogen synthase kinase 3-a 
(GSK-3(x) and glycogen synthase kinase 3-0 (GSK-30). The two kinases were named due 
to their ability to phosphorylate and inactivate glycogen synthase, although roles in many 
other signalling pathways have now been shown (Grimes and Jope, 2001; Harwood, 2001). 
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The expression pattern of the two are highly similar (Woodgett, 1990), but only GSK-30 
will substitute for Shaggy in the Wg pathway (Ruel et al., 1993). However, GSK-3ß knock- 
out mice develop normally up until birth, suggesting that GSK-3a can partially compensate 
for the loss of GSK-3ß. (Hoeflich et al., 2000). All future reference to GSK-3 shall refer to 
the ß isoform, as it remains the better studied with reference to Wnt signalling. 
Drosophila genetics has established that Wg acts positively on Dsh which is upstream of 
Shaggy, with the net result being the accumulation of Armadillo (Arm), the Drosophila 
homologue of ß-catenin (Cadigan and Nusse, 1997). In the absence of Wg signalling, GSK- 
3 phosphorylates Arm, targeting it for breakdown via the 3'proteasome. 
Efficient phosphorylation of many GSK-3 substrates requires the presence of another 
phosphorylated residue, optimally located four amino acids C-terminal to the GSK-3 target 
site (Frame and Cohen, 2001). The newly phosphorylated residue may then prime a further 
GSK-3 phosphorylation event and this may continue until there ceases to be an 
appropriately positioned serine or threonine residue. This type of phosphorylation cascade 
is thought to be the mechanism by which GSK-3 regulates 0-catenin via phosphorylation at 
its N-terminus. In addition to phosphorylating 0-catenin, GSK-3 also phosphorylates and 
stabilises Axin and also phosphorylates APC, which promotes its binding with ß-catenin 
(Rubinfeld et al., 1996; Yamamoto et al., 1999). 
A >50% reduction in activity is seen in GSK-3 purified from cells treated with Wg- 
conditioned medium (Cook et al., 1996), but the exact mechanism of GSK-3 inhibition in 
the Wnt pathway is not entirely clear. Several mechanisms of GSK-3 regulation have been 
demonstrated. Phosphorylation at Tyr-216 is thought to be essential for GSK-30 function, 
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and so the action of a phosphatase would reduce GSK-3 activity. However, there is no 
evidence to suggest that a phosphatase inactivates GSK-3 in the Wnt pathway. 
GSK-3 is also inactivated via phosphorylation at Ser-9 and several kinases have been 
shown to phosphorylate GSK-3 at this position. These include; cAMP-dependent protein 
kinase (PKA); PKB/Akt, protein kinase C (PKC); and p70 S6 kinase and p90Rsk (Cross et 
al., 1995; Eldar-Finkelman et al., 1995; Fang et al., 2000; Goode et al., 1992; Sutherland et 
al., 1993). GSK-3 is central to the insulin signalling pathway, where it is inactivated 
following phosphorylation at Ser-9 by PKB/Akt (Cross et al., 1995). However, PKB 
activity is insufficient to significantly increase TCF-dependent transcription (Ding et al., 
2000). Wg-induced inactivation of GSK-3 is sensitive to the PKC inhibitor Ro31-8220 
(Cook et al., 1996). This could, of course, be via phosphorylation of a second protein; for 
example, Dvl, although the in vitro data supports a more direct interaction. Dvl does 
however, have a putative PKC binding site in its DEP domain. (Mudher et al., 2001). 
It may be that a change in the subcellular localisation of GSK-3 is responsible for the loss 
of ß-catenin phosphorylation following Writ signalling, or maybe it is a combination of this 
and direct inactivation. It has already been established that Dvl binds both Axin and Fratl. 
Axin and Fratl also bind GSK-3 (Li et al., 1999; Yost et al., 1996). Dvl, Axin and GSK-3 
can form a ternary complex, where Axin acts as a bridge for the other two proteins. Fratl 
can be recruited to the complex, probably by Dvl. The finding that the Dvl binding domain 
of either Fratl or Axin will inhibit Wnt induction of downstream target genes suggests that 
their interactions with GSK-3 may be an important step in the pathway (Li et al., 1999). 
Exactly how Fratl, Axin and Dvl bring about Wg-induced inactivation of GSK-3 remains 
unclear. The Dvl binding site of Axin overlaps with the ß-catenin binding site (Julius et al., 
2000), which suggests a mechanism whereby Dvl competes with 3-catenin for binding to 
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Axin following Wnt stimulation. GSK-3 would become separated from ß-catenin, allowing 
levels of the latter to rise. 
In addition to Dishevelled and Axin, GBP (GSK-3 Binding Protein)/Frat (frequently 
rearranged in advanced T-cell lymphomas) also binds GSK-3. A role for GBP/Frat in the 
Wnt pathway was proposed following the discovery that in addition to binding GSK-3, the 
protein also interacts with Dishevelled (Li et al., 1999). A role for GBP/Frat in the nuclear 
export of GSK-3 has recently been proposed, following the finding that Frat-binding 
mutants of GSK-3 accumulate in the nucleus and a peptide of Frat that competes for 
binding with GSK-3 causes endogenous GSK-3 to accumulate in the nucleus (Franca-Koh 
et al., 2002). 
The current model for Frat action proposes that Dishevelled recruits Frat to the Axin 
complex following Wnt stimulation. Frat then titrates GSK-3 from Axin, inhibiting GSK-3 
dependent phosphorylation of ß-catenin, allowing levels of the latter to rise (Li et al., 1999; 
Salic et al., 2000). To date, no change in the localisation of Frat or GSK-3 has been 
observed following stimulation of cells with either Wnt or insulin. 
1.6 Protein Phosphatase 2A (PP2A) 
The association of PP2A with the Wnt pathway arose from the observation that it will bind 
the C-terminus of Axin in vitro (Hsu et al., 1999). This suggested that PP2A may interact 
with the Axin/APC/GSK-3/0-catenin complex to modulate the effect of GSK-3 
phosphorylation of ß-catenin and/or other proteins. 
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The PR61 subunit of PP2A has been shown to inhibit ß-catenin-dependent TCF activation 
and Xenopus axis duplication, without dephosphorylation of Axin or ß-catenin degradation 
(Yamamoto et al., 2001). The exact target of PP2A in the Writ pathway remains unclear. 
1.7 Casein Kinase 1 
Two Casein Kinase 1 family members appear to be active in the Wnt pathway. Casein 
Kinase lE (CK1c) is a positive regulator of Wnt signalling. Overexpression of CK1E 
mimics Wnt signalling, inducing a secondary axis in Xenopus, stabilising ß-catenin and 
stimulating gene expression (Sakanaka et al., 1999). Both kinase-dead CK1E and anti-sense 
CK1E inhibit Wnt signalling. Furthermore, CK1c has been found in a complex with Axin 
and Dishevelled (Sakanaka et al., 1999). The kinase is brought into the complex by the 
ankyrin repeat protein Diversin (Schwarz-Romond et al., 2002). 
Phosphorylation of Ser-33 and Ser-37 of ß-catenin is dependent on prior phosphorylation of 
residues Thr-41 and Ser-45 (van Noort et al., 2002). Despite Ser-45 being the most frequent 
tumour mutation spot (Polakis, 2000), GSK-3 is unable to phosphorylate this residue in 
vitro (Hagen and Vidal-Puig, 2002). CK1a can phosphorylate ß-catenin in vitro at Ser-45, 
in an Axin-dependent manner (Liu et al., 2002; Amit et al., 2002). CK1a phosphorylation 
of Ser-45 is both necessary and sufficient to prime the GSK-3-mediated phosphorylation of 
Thr-41. Furthermore, CKla phosphorylation of ß-catenin has been shown to be inhibited 
by Wnt. This suggests a mechanism where in the absence of Wnt stimulation, Axin 
facilitates CK1a phosphorylation of ß-catenin at Ser-45, initiating a GSK-3 
phosphorylation cascade ending at Ser-33.3Trcp is then able to bind ubiquitinated 
catenin, targeting it for breakdown via the proteosome. 
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1.8 Axin and APC 
Axin is the product of the fused locus. Mutations have pleiotropic effects on development, 
including the formation of axial duplications in homozygous vertebrate embryos (Zeng et 
al., 1997). Axin shows similarity to RGS (regulators of G-protein signalling) proteins and 
to the N-teminus of Dsh proteins. Injection of Axin mRNA inhibits dorsal axis formation in 
Xenopus embryos by interfering with Writ signalling (Zeng et al., 1997). Ectopic expression 
in dorsal blastomeres of Xenopus embryos causes ventralisation, indicating an inhibitory 
function in normal axis formation. Conversely, ventral injection of RNA encoding a mutant 
Axin lacking the RGS domain leads to axis duplication, suggesting that this mutant is a 
dominant-negative. Co-injection of Axin RNA with the RNA of Writ pathway components 
reveals that it acts downsteam of Wnt, Dsh, and GSK-3 but upstream of ß-catenin (Fagotto 
et al., 1999). 
What is the mechanism by which Axin inhibits axis duplication? The Axin protein contains 
binding sites for both GSK-3 and ß-catenin, with all three forming a ternary complex when 
co-expressed in COS cells (Ikeda et al., 1998). GSK-3 does not significantly phosphorylate 
ß-catenin in vitro (Rubinfeld et al., 1996). However, the addition of Axin significantly 
increases GSK-3 phosphorylation of (3-catenin in vitro (Ikeda et al., 1998), suggesting that 
at least one of the roles of Axin is to enhance GSK-3 phosphorylation of ß-catenin. This 
could be through bringing GSK-3, CKlet and 0-catenin together. 
Conductin is a paralogue of Axin, sharing 45% amino acid identity (Behrens et al., 1998). 
Biochemically it behaves like Axin, promoting the degradation of J -catenin. Unlike Axin 
though, Conductin is selectively expressed in the mouse embryo (Behrens et al., 1998). 
Conductin is upregulated in colonic and hepatocellular carcinomas (Lustig et al., 2002). 
Furthermore, Conductin expression in colorectal tumour cells can be blocked through the 
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expression of dominant-negative TCF, and is upregulated following Wnt-1 stimulation of 
cultured cells or in Min mice (mice null for APC) (Lustig et al., 2002). The evidence to date 
therefore suggests that Conductin itself is a target of Wnt signalling, acting in a negative 
feedback loop. In a normal cell, Conductin can scaffold ß-catenin into the degradation 
complex containing GSK-3, promoting ß-catenin breakdown. Wnt-1 stimulation stabilises 
ß-catenin, allowing it to complex with TCF and activate target genes, one of which is 
Conductin, a negative regulator of ß-catenin. 
Mutations in the APC (adenomatous Polyposis coli) gene are responsible for up to 80% of 
both inherited and sporadic forms of colon cancer (Miyoshi et al., 1992). The APC gene 
encodes a large (approximately 310kDa) protein with several distinct motifs; namely, an N- 
terminal oligomerisation domain, seven armadillo repeats, three repeats of 15 amino acids, 
seven repeats of 20 amino acids, and a basic domain (see Polakis, 1999). The first three of 
the 20 amino acid repeats of APC encompass what has been termed the mutation cluster 
region (MCR) and contains the majority of somatic APC mutations seen in colon cancer 
(Miyoshi et al., 1992). The oligomerisation domain is required for the homodimerisation of 
APC molecules, whilst the C-terminal basic domain binds microtubules. It is the 15 amino 
acid and 20 amino acid repeats that are of greatest relevance to cancer. The three 15 amino 
acids repeats each bind ß-catenin independently, whilst the seven 20 amino acid repeats 
each bind ß-catenin in a phosphorylation-dependent manner. It is the deletion of four or 
five of the 20 amino acid repeats that is most commonly associated with incidents of colon 
cancer (Polakis, 1997). Experimental deletions to APC, showed that loss of ß-catenin 
regulation occurred as the 3' boundary of the MCR was crossed. However, these deletions 
also represent a loss of 2 of the 3 binding sites for Axin (Behrens et al., 1998), suggesting 
another route to ß-catenin mis-regulation. 
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The over-expression of Axin in APC-mutant cancer cells is sufficient to downregulate ß- 
catenin (Hart et al., 1998). So what is the precise role that APC plays in the downregulation 
of (3-catenin? Several theories exist and one attractive idea has resulted from the in vitro 
reconstruction of Axin-mediated ß-catenin degradation (Salic et al., 2000). APC may be 
required to sequester ß-catenin throughout the cytoplasm, or may bind nuclear ß-catenin 
and transport it to the Axin complex (Bienz, 1999). Two pieces of evidence support this 
theory. Firstly, the finding that APC contains nuclear export sequences (Rosin-Arbesfeld et 
al., 2000) and, secondly, APC has been shown to move along microtubules and concentrate 
at their growing ends in epithelial cells (Mimori-Kiyosue et al., 2000). 
1.9 Wnt signalling in Caenorhabditis elegans 
Three highly divergent ß-catenin homologues with different functions have been identified 
in C. elegans: WRM-1, BAR-1 and HMP-2. (Korswagen et al., 2000). BAR-1 is the only 
one that interacts with the TCF-like transcription factor POP-1 to activate expression of 
Wnt target genes. WRM-1 activates the kinase LIT-1/Nemo-like kinase, which participates 
in MAP kinase signalling and opposes signalling by POP-1. HMP-2 interacts with the C. 
elegans cadherin, HMR-1 to regulate adhesion. 
A non-canonical Wnt pathway in C. elegans is required for the control of asymmetric cell 
divisions (for a review, see Thorpe et al., 2000). The Wnt homologue MOM-2 (more 
mesoderm-2) binds to the Fz homologue MOM-5, to activate a signalling cascade which is 
required for the induction of endoderm in the early embryo (Rocheleau et al., 1997; Thorpe 
et al., 1997), and the specification of several asymmetric cell divisions during larval 
development (Herman and Horvitz, 1994; Herman et al., 1995). 
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A mitogen-activated protein kinase (MAPK) pathway, consisting of MOM-4/TAK1 and 
LIT-1/NLK, acts in parallel to the MOM-2/Wnt pathway to downregulate POP-1 levels 
(Kaletta et al., 1997; Meneghini et al., 1999; Rocheleau et al., 1999). The reduction in POP- 
1 levels leads to derepression of end-1 and the induction of endoderm development (Lin et 
al., 1995). Therefore, instead of turning POP-1/TCF into a transcritional activator, the 
MOM-2IWnt/MAPK pathway blocks the repressive function of POP-1. Figure 1.3 
illustrates this non-canonical Wnt pathway. 
BAR-1 has been shown to bind PRY-1, the C. elegans Axin homologue, and regulate a 
second and more canonical Wnt pathway (Korswagen et al., 2002). This suggests that two 
parallel pathways, one canonical and one non-canonical, transduce Wnt signals in worms 
(see Korswagen, 2002). 
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Figure 1.3 Non-canonical Wnt signalling in C. elegans 
MOM-2/Wnt signalling, in combination with a MAPK pathway, leads to depression of end- 
1. WRM-1 and LIT-1/NLK form a complex that is activated by MOM-4/TAK1 to 
phosphorylate and inactivate POP-1. Both the GSK-3 homologue SGG-1 and the APC 
related protein APR-1 appear to function as positive regulators of the pathway. 
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1.10 ß-catenin and cell-cell adhesion 
1.10.1 Adhesion defects associated with the loss of ß-catenin or E-cadherin 
The loss of zygotic DE-cadherin (the Drosophila homologue of E-cadherin) is associated 
with the reduction of morhogenetic movements, the disintegration of the malpighian tube 
into small spherical structures and the blocking of the tracheal network (Cox et al., 1996; 
Uemura et al., 1996). 
In Drosophila, mutations to germ line arm lead to the production of small eggs, which is 
presumed to be from a lack of resistance to the pressure exerted by the muscular 
contractions of the egg chamber, associated with a loss of adhesion (Peifer et al., 1993). In 
addition, mutations to arm leads to the loss of adhesion between the germ cells, but not the 
follicle cells, which leads to an incorrectly positioned oocyte (Peifer et al., 1993). 
ß-catenin knock-out mice show defects in the development of the embryonic ectoderm. 
Cells detach from the ectodermal layer and become dispersed into the proamniotic cavity 
(Haegel et al., 1995). In addition, knock-out mice fail to form mesoderm. 
1.10.2 ß-catenin and adherens junctions 
Regulated cell-cell adhesion is crucial in the development of a multicellular organism. 
Intercellular junctions usually form at sites of cell-cell contact between neighbouring cells; 
epithelial cells are connected by a combination of different adhesive structures (see figure 
1.4). Near to the apical surface, tight junctions create a seal between adjacent cells 
restricting the movement of molecules between them. Below the tight junctions are the 
adherens junctions, which join the actin cytoskeleton of adjacent cells, forming an adhesion 
belt, also known as the zonula adherens. Nearer to the basal surface are the desmosomes 
and the gap junctions. The desmosomes join the intermediate filaments of adjacent cells, 
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whilst the gap junctions contain channels that allow small molecules and ions to pass from 
one cell to another, rather like the plasmodesmata of plants. The hemidesmosomes anchor 
the intermediate filaments inside the cell to the basal lamina. 
Cadherin molecules play essential roles in development, cell polarity and tissue 
morphology (Takeichi, 1991). E-cadherin has an extracellular domain of five cadherin-type 
repeats. It is these repeats that interact in a calcium-dependent fashion with the cadherin 
molecules on opposing cell surfaces to regulate cell adhesion (Nagar et al., 1996). The 
cytoplasmic domain of E-cadherin was found to associate with a-, 0- and y-catenin (Ozawa 
et al., 1989). 
The binding of ß-catenin to the cytoplasmic tail of E-cadherin introduces a-catenin to the 
adherens junction complex (for a review, see Nagafuchi, 2001). a-catenin, in turn, links 
with the actin cytoskeleton. y-catenin, or plakoglobin, is a paralogue of (3-catenin, sharing 
high sequence similarity (Cowin et al, 1986). Plakoglobin is mainly found localised at 
desmosomes, where it binds the desmosomal cadherin proteins, desmogleins and 
desmocollins. Plakoglobin is also able to bind to E-cadherin, but with weaker affinity than 
ß-catenin (Knudsen and Wheelok, 1992; Peifer et al, 1992). 
The importance of ß-catenin localisation at the adherens junctions is two-fold; (1) It is 
required for maintaining the integrity of the adherens junctions: loss of ß-catenin from 
adherens junctions leads to reduced adhesion and thus increased invasiveness and 
metastasis of tumour cells (Birchmeier et al., 1993); (2) When not bound to E-cadherin, 13- 
catenin can move to the nucleus and activate target genes of the Wnt pathway, another 
possible factor in the progression of certain types of tumour. 
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Figure 1.4 Schematic of epithelial cell junctions, highlighting the major protein 
components 
E-cadherin cell adhesion molecules bind homophilically to one another, to connect adjacent 
cells. ß-catenin links the cadherin molecules with the actin cytoskeleton via a-catenin, to 
provide a continuous belt of actin across the epithelium. 
1.10.3 Tyrosine phosphorylation of ß-catenin 
There is no evidence that phosphorylation of ß-catenin by GSK-3 plays a role in its binding 
at adherens junctions. However, tyrosine phosphorylation (at Tyr-654) has been shown to 
decrease the interaction of ß-catenin with E-cadherin in vivo (Kinch and Burridge, 1995; 
Roura et al., 1999). Elucidation of the crystal structure of the ß-catenin/E-cadherin complex 
demonstrated that Tyr-654 is a key residue in this interaction (Huber and Weis, 2001). 
p120-catenin is a further catenin molecule often found associated with the adherens 
junctions, and was originally identified as a substrate for the pp60src Tyr kinase (Kanner et 
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al., 1991). In addition, pp60`-" Tyr kinase, or its viral homologue pp60v-$`°, has been. 
reported to promote the dissociation of the adherens junction complex and will 
phosphorylate ß-catenin in vitro (Roura et al., 1999). However, this does not exclude the 
possibility that pp60`-"c could activate another Tyr kinase responsible for the 
phosphorylation of ß-catenin. For example, the Fer kinase and the EGF receptor, which are 
both Tyr kinases associated with ß-catenin (Rosato et al., 1998; Shibamoto et al., 1994). 
The implication of src Tyr kinases and EGF signalling in the dissociation of ß-catenin from 
adherens junctions would propose further ways in which (3-catenin can promote 
oncogenesis. 
1.11 Dictyostelium discoideum 
The cellular slime mould Dictyostelium discoideum is a simple eukaryote that undergoes a 
programme of multicellular development with similarities to that of animal development. 
Cells grow as unicellular amoebae and divide with a short generation time, making it 
simple to obtain large numbers for use in biochemical assays. A 34Mb haploid genome 
makes Diclyostelium genetically tractable and a cDNA sequencing project has, to date, 
yielded 6,400 independent sequences, which represents 70-80% of all of the expected genes 
(Urushihara, 2002). 
1.11.1 Dictyostelium development 
It is the starvation of Dictyostelium that initiates the developmental programme, leading to 
multicellularity. Hemispherical mounds of approximately 100,000 amoebae form following 
cAMP-induced chemotaxis. From the mound, a small tip appears which extends until a 
finger-like structure, the slug, is produced. The slug then falls over and, guided by photo- 
and thermotaxis, migrates to the soil surface in order to produce a fruiting body. See figure 
1.5 for the timing of events. 
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Figure 1.5 Dictyostelium development 
In the presence of a plentiful food source, amoebae grow and divide. Upon starvation, 
cells coalesce into adherent cell 'streams' which tighten to form the mound. The 'tip' then 
develops from the mound and extends to make a slug, which will either culminate, or 
migrate until conditions are more favourable for making a fruiting body. (Figure 
reproduced with permission from A. J. Harwood). 
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The natural habitat of Dictyostelium discoideum is the forest floor; they were first isolated 
from decaying leaves in North America by Kenneth Raper in 1935 (Raper, 1935). 
Dictyostelium amoebae usually feed on bacteria. They sense the onset of starvation via the 
secreted factor PSF (prestarvation factor). PSF is required for the expression of early 
starvation genes (Rathi and Clarke, 1992). Amoebae synthesise PSF during the growth 
phase and it accumulates in the surrounding microenvironment. However, the gene 
inductive effect of PSF is inhibited by the presence of bacteria. In the absence of a food 
source PSF accumulates, which results in the upregulation of the cAMP-dependent protein 
kinase (PKA). PKA activity is required for the upregulation of several genes, including 
adenylyl cyclase A (aca) and the cAMP receptor cAR1 (Schulkes and Schaap, 1995). The 
activation of adenylyl cyclase leads to the secretion of cAMP in the nanomolar range. ACA 
becomes activated via cAR1, which becomes adapted following exposure to CAMP. 
Consequently, ACA becomes inactive until extracellular cAMP is removed by 
phosphodiesterase (PDE) (see Kimmel and Firtel, 1991). This leads to the relay of cAMP 
pulses across the field of aggregating cells (Van Haastert, 1995). In addition to emitting 
cAMP pulses, cells respond to cAMP by chemotaxing towards the source, hence the field 
of developing cells move towards the aggregation centre. 
In addition to the cAMP relay, cells also need to sense the accumulation of a secreted factor 
called CMF (conditioned medium factor). When the number of starving cells within a 
10mm proximity reaches the required density, the concentration of CMF will reach a level 
that induces cells to aggregate. Once an aggregate is formed, micromolar levels of cAMP, 
in combination with CMF, induce the expression of prespore and prestalk genes (Gomer et 
al., 1991; Mehdy and Firtel, 1985). Within the slug, the posterior two thirds are composed 
of prespore cells, whilst the anterior third is composed of prestalk cells. These two cell 
types will subsequently give rise to the spore and stalk cells, respectively, of the mature 
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fruiting body (MacWilliams and Bonner, 1979). Once the slug begins to culminate, prestalk 
cells in the tip move down through the developing prespore mass and embed into the basal 
disc (see Dormann et al., 1996). As the stalk develops, it becomes enclosed in a protein- 
and cellulose-containing tube (Grimson et al., 1996). As the prestalk cells enter the tube, 
they become terminally differentiated, forming vacuolated stalk cells. The stalk grows by 
elongation, via the addition of stalk cells to its top, which raises the spore head up to the top 
of the stalk. 
Conditions have been established whereby, in the absence of multicellularity, spore and 
stalk cells can be formed in monolayers (Berks and Kay, 1988; Town et al., 1976). This 
approach has led to the discovery of further factors required for cell differentiation in 
Dictyostelium. Differentiation-inducing factor-1 (DIF-1) is a small chlorinated alkyl 
phenone required for the determination of pre-stalk cell fate (Kopachik et al., 1983; Morris 
et al., 1987). DIF-1 promotes the differentiation of pre-stalk cells, whilst repressing the 
differentiation of pre-spore cells (Early and Williams, 1988). 
SDF-1 and SDF-2 (spore differentiation factor 1& 2) are peptides that promote terminal 
spore differentiation under submerged conditions (Anjard et al., 1997). The two SDF 
peptides appear to regulate independent pathways, but both may require phosphorylation by 
PKA (Anjard et al., 1997). SDF-1 and SDF-2 are produced and secreted at different times 
in development and are released in single bursts, which may represent an irreversible step 
in cell differentiation (Anjard et al., 1998). 
Ore sent-10,601) 
Ammonia and adenosine both affect de iatan. Ammonia accumulates as cells develop, 
and if sufficient levels do not evaporate, aggregation is delayed and slugs will migrate 
(Anjard et al., 1997). The addition of well-buffered substrates leads to the immediate 
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production of a fruiting body, thought to be due to the neutralisation of ammonia. 
Adenosine is thought to bind cells on the cARI receptor (Newell, 1982). Binding of 
adenosine inhibits the cAMP relay and blocks adaptation in perfusion experiments 
(Theibert and Devreotes, 1984). Some evidence also exists for a role in later development 
(Schaap and Wang, 1986). 
1.11.2 GSK-3 signalling in Dictyostelium 
The Dictyostelium GSK-3 homologue, GskA, has been shown to be crucial for the early 
prespore/prestalk cell patterning event, although not essential for cell differentiation 
(Harwood et al., 1995). In the gskA null mutant, the prestalk cell population is grossly 
expanded at the expense of the prespore cell population and cAMP repression of both ecmB 
expression (a marker of pre-stalk cells) and stalk formation is lost in monolayer culture 
(Harwood et al., 1995). A rise in GskA activity is seen at the onset of multicellular 
development, when ecmB and pspA (a marker of pre-spore cells) are first expressed. This 
increase in activity is mediated by the cAMP receptor cAR3; cAR3 null mutants have many 
features common to the loss of gskA (Plyte et at., 1999). The Dictyostelium tyrosine kinase 
Zak-1 has been shown to increase GSK-3 activity in vitro and is required for the increase in 
GskA activity seen in development (Kim et al., 1999). It is regulated by cAMP via cAR3 
and mutants also have effects similar to loss of gskA. Conversely, loss of the lower-affinity 
cAMP receptor, cAR4, leads to greater activity of GskA and prolonged tyrosine 
phosphorylation when treated with cAMP (Ginsburg and Kimmel, 1997; Kim et al., 2002). 
This suggests that a tyrosine phosphatase may be downstream of cAR4. Figure 1.6 
illustrates this dual regulation of GskA by cAMP. 
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Figure 1.6 cAMP regulation of GskA 
cAMP binding at the cAR3 receptor activates GskA via the tyrosine kinase ZAK-1. GskA 
induces pre-spore gene expression whilst at the same time inhibiting pre-stalk gene 
expression. cAMP binding at the cAR4 receptor inhibits GskA via a tyrosine phosphatase. 
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The Axin binding motif of GSK-3 is conserved in GskA and mutation leads to a reduction 
in the expression of the prespore gene pspA (Fraser et at., 2002). This apparent Axin- 
dependent GSK-3-mediated gene expression suggests that Axin and other downstream 
components of the Wnt pathway may be present in Dictyostelium. 
A ß-catenin homologue, Aardvark (Aar), has been cloned in Dictyostelium (Grimson et al., 
2000). An examination of the Aar sequence reveals the presence of ten armadillo repeats 
(ß-catenin has 12). It also has a putative ct-catenin binding site, which aligns with that of ß- 
catenin, as well as potential GSK-3 phosphorylation sites. Aar possesses additional N- 
terminal sequence compared with ß-catenin and lacks the C-terminal trans-activation 
domain. 
Aar is required for pspA expression in cell suspension, where there is an absence of cell 
contacts (Grimson et al., 2000). This shows that Aar, like ß-catenin, is a signal transduction 
molecule. In addition, expression of pspA is both delayed and reduced during development 
in the aar null mutant and aar mutants produce 50% less spores than wild type cells. 
Overexpression of Aar in the gskA null mutant fails to restore high pspA expression, 
suggesting that the GSK-3/ß-catenin relationship is positive in Dictyostelium (Grimson et 
al., 2000). This appears similar to the non-canonical Wnt pathway of C. elegans where 
GSK-3 acts positively on WRM-1, the ß-catenin homologue, for endoderm induction 
(Korswagen, 2002). 
1.11.3 Aar and cell adhesion 
As with ß-catenin, in addition to a cell signalling function, Aar also has a structural 
function (Grimson et al., 2000). Aar localises to cell-cell contacts, which have the 
morphology of adherens junctions. aar mutants develop, but fruiting bodies are 
45 
mechanically weak, and the majority collapse onto the substratum. Transmission electron 
microscopy of longitudinal sections of the stalk tube reveal a loss of actin from the 
adherens junctions in aar mutant fruiting bodies, further supporting a role for Aar in the 
formation of Dictyostelium adherens junctions (Grimson et al., 2000). Conversely, 
overexpression of aar in wild type cells leads to the mis-localisation of large amounts of 
actin at the adherens junctions, causing the membrane to buckle. This results in the 
instability of fruiting bodies, but the phenotype is not as severe as the aar mutant. 
The fruiting body of wild type Dictyostelium contains just one single stalk, positioned in 
the centre of the stalk tube. Stalk cells only normally differentiate inside the stalk tube, but 
in aar mutant fruiting bodies stalk cells can differentiate outside of the stalk tube (Coates et 
al., 2002). This can lead to the formation of additional stalks. The exact mechanism behind 
ectopic stalk formation is unclear. One possibility is that the loss of adherens junctions 
associated with the aar mutant disrupts the integrity of the stalk tube. This would allow the 
stalk-inducing factor to escape, giving rise to the formation of ectopic stalks. This 
illustrates how changes in structure can lead to effects on signalling. 
1.12 Aims of thesis 
The observation that the GskA-Aar interaction appears to mimic that of the GSK-3-WRM-1 
interaction in C. elegans was an interesting one. Further analysis of the Dictyostelium, and 
other, non-canonical Wnt-like signalling pathways may reveal important findings about 
both the evolution and function of these pathways in mammalian development. 
Whilst the structure of Aar has been examined at the sequence level, no physiological 
relevance has been attributed to features such as the putative a-catenin binding and GSK-3 
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phosphorylation sites. At the outset of this project, the following questions were to be 
addressed: 
9 Does GskA directly phosphorylate Aar? 
" What physiological roles can be assigned to the various features of the Aar sequence? 
" What does the subcellular localisation of Aar reveal about Aar protein function? 
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Chapter 2 
Materials and Methods 
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2.1 List of abbreviations used 
aar, Aar, aar Aardvark gene, protein product and knock-out 
AEBSF 4-(2-Aminoethyl)benzenesulphonyl Fluoride 
Ala Alanine 
ampR Ampicillin resistant 
APS Ammonium persulphate 
Arg Arginine 
bp base pairs 
BSA Bovine serum albumin (Fraction V) 
°C degrees Celsius 
cAMP Adenosine 3': 5'-cyclic monophosphate 
cDNA complementary DNA 
Ci Curie 
Cys Cysteine 
dATP 2'-Deoxyadenosine 5'-triphosphate 
dCTP 2'-Deoxycytosine 5'-triphoshate 
ddHZO Double distilled water (Millipore) 
DEAE Diethylaminoethanol 
DEPC Diethyl pyrocarbonate 
dGTP 2'-Deoxyguanosine 5'-triphosphate 
DIF Differentiation Inducing Factor 
DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
DTT DL-Dithiothreitol 
dTTP Thymidine 5'-triphosphate 
ECL Enhanced chemiluminescence 
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W 
EDTA Disodium Ethylenediaminetetra-acetic acid 
EGTA Ethylene Glycol-bis(B-aminoethylether)-N, N, N'N'-tetraacetic acid 
g gram 
Glu Glutamic acid 
Gly Glycine 
His Histidine 
His-tag 6x histidine epitope tag 
hrp Horseradish peroxidase 
IgG Immunoglobulin 
kb kilobase 
kDa kiloDalton 
I litre 
Leu Leucine 
M molar 
MBq Mega bequerels 
m metre 
m (prefix) milli (10.3) 
µ micro (10-6) 
Met Methionine 
min minutes 
mol moles 
MOPS 3-(N-Morpholino)propanesulphonid acid 
mRNA Messenger RNA 
n nano (109) 
ODx Optical density at x nm 
p Pico (10'12) 
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32P Radioactive phosphorous 
PBS Phosphate-buffered saline 
PBST PBS/0.1% Tween-20 
pfu Plaque-forming units 
Phe Phenylalanine 
Pro Proline 
RNA Ribonucleic acid 
rpm Revolutions per minute 
s seconds 
SDS Sodium dodecyl sulphate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
Ser Serine 
SSC Standard sodium citrate 
TBE Tris/Borate/EDTA 
TE Tris/EDTA 
TEM Transmission electron microscopy 
TEMED N'N'N'N'Tetramethylethylenediamine 
Thr Threonine 
Tris Tris (hydroxymethyl) methylamine 
TRITC Tetramethylrhodamine B Isothiocyanate 
Tyr Tyrosine 
UV Ultraviolet 
V Volt 
Val Valine 
v/v volume for volume 
w/v weight for volume 
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2.2 Dictyostelium culture and transformation 
2.2.1 Cell culture 
Vegetative cells were grown at 22°C, either on lawns of Klebsiella aerogenes plated on 
Sussman's medium, or in shaking culture in axenic medium containing 0.1mg/ml 
streptomycin (and 20. tg/ml G418 or 10 tg/ml if selecting for overexpressors or knock-outs, 
respectively). Ax2 was used as the wild type strain throughout this thesis. 
For long term storage, 107 cells or more were resuspended in lml horse serum containing 
5% DMSO in a 2m1 cryovial (Nunc) and slowly frozen at -80°C, before being transferred 
to liquid nitrogen stores. 
2.2.2 Transformation of Dictyostelium by electroporation 
107 log phase (1-2x 106/ml) cells were spun out of axenic medium at 700g for 4min and 
washed once in sterile electroporation buffer (50mM sucrose in KK2) before resuspension 
in 800gl of the same buffer. The cell suspension was then incubated on ice for 10 min and 
electroporated in 50x4mm electroporation cuvettes using a BioRad Gene Pulser (at 1.6KV 
with a capacitance of 3µF). Cells were then incubated on ice for 10 min, before the addition 
of 8µl of 1mM MgC12/lmM CaC12 and further incubation for 15 min at room temperature 
(RT). The contents of each cuvette were split between two axenic plates. Media containing 
20µg/ml streptomycin was added. After 24 hours, the media was replaced with media 
containing 20gg/ml strep, 20µg/ml G418 and 1% (v/v) heat-killed E. coli (strain B/R). 
2.3 Molecular biology 
2.3.1 Agarose gel electrophoresis of DNA 
Agarose gels were prepared in 0.5xTBE (see section 2.6 for recipe) as described previously 
(Sambrook, 1989). The percentage of the gel was determined by the size of DNA fragments 
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to be resolved. Ethidium bromide (O. 5 ig/ml) was included in gels for visualisation of 
DNA under UV light. DNA was loaded in 10% (v/v) DNA loading buffer. 1µg of size 
markers was also loaded (1kb A. digest, Gibco). 
2.3.2 Amplification of DNA by Polymerase Chain Reaction (PCR) 
5014 reactions were set up in thin-walled 200µ1 tubes (Radleys) or multiwell plates (Perkin 
Elmer), as follows: 
" 0.1µg aar plasmid DNA (or ddHZO control) 
" 0.2µl of lOOpmol4tl 5' primer (or ddH2O control) 
" 0.2µl of lOOpmol/gl 3' primer (or ddH2O control) 
" 5µl of dNTPs (200µM dATP, dCTP, dTTP and dGTP - Amersham Pharmacia Biotech), 
" 5µl lx Pfu buffer (Stratagene) 
" 2.5 units of Taq polymerase and 2.5 units of recombinant Pfu polymerase (Stratagene) 
Volume made up to 50µl using ddH2O 
For a standard amplification of aar DNA up to 2.5Kb in length, the DNA was denatured at 
95°C for 30s then subjected to 28 cycles of 95°C for 30s, 55°C for 30s, 65°C for 5 min 
followed by a final extension step at 65°C for 10 min before storage at 4°C. For 
amplification of larger PCR products, extension times of 10 min were used in the cycles. 
2.3.3 TOPO Cloning reactions 
All PCR products were cloned into the pCRII-TOPO vector (Invitrogen) and subsequently 
transformed into TOP10 chemically competent E. coli (see below). The TOPO cloning 
reaction utilises the 3' deoxyadenosine overhang of Taq amplified PCR products. The 
linearised pCR-II vector contains overhanging 3' deoxythymidine. These overhangs ligate 
efficiently with the PCR products due to the activity of topoisomerase which is covalently 
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bound to the vector. Resulting colonies were analysed by miniprep and digest analysis (see 
sections 2.3.6 and 2.3.7). 
2.3.4 Bacterial permanents 
Glycerol stocks of positive colonies were made by the addition of 0.5m1 50: 50 (v/v) L- 
broth/glycerol to 0.5m1 of the overnight culture; stocks were stored at -80°C. The pCRII 
vector contains the M13 and T7 promoter sites, facilitating the sequencing of the PCR 
insert. 
2.3.5 Plasmid DNA preparations - maxiprep 
For large-scale plasmid DNA preps, QIAGEN Plasmid Maxi kits (Qiagen Ltd) were used, 
which employ a variation on the alkaline lysis method of DNA preparation. These kits 
utilise columns containing anion-exchange resin to covalently bind plasmid DNA to 
immobilised diethylaminoethanol (DEAE) groups over a wide range of salt conditions. 
In brief, plasmid-containing E. coli cells were grown overnight in a 250m1 L-broth culture, 
supplemented with 100µg/ml ampicillin. Cells were lysed with SDS and the lysate passed 
through the columns by gravity flow. Protein, carbohydrates and small metabolites were 
washed from the column with low-salt buffers, while the plasmid DNA remained tightly 
bound. Plasmid DNA was then eluted with a high-salt buffer. Up to 500µg plasmid DNA 
per column may be isolated by this method. (Glycerol stocks were made as per section 
2.3.4 and stored at -80°C). 
2.3.6 Plasmid DNA preparations - miniprep 
For smaller scale plasmid preps, requiring sequencing quality DNA, spin miniprep kits 
(MoBio Laboratories Inc. ) were used. These utilise the same principle as the QIAGEN 
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Plasmid Maxi kits to purify plasmid DNA. A typical yield from an individual prep is 5- 
10µg plasmid DNA from a 1.5m1 bacterial culture. 
Small-scale DNA plasmid preps for all applications other than sequencing were carried out 
via the rapid boiling method (Harwood, 1996). 1.5m1 of plasmid-containing E. coli were 
spun out of medium by centrifugation for lmin at 12,000g in a benchtop centrifuge. Pellets 
were resuspended in l00µ1 of lmg/ml lysozyme/STET mix (see section 2.6 for STET 
recipe), and vortexed to break up the pellet. Samples were boiled for 45s and centrifuged 
for 10 min at 12,000g. The resulting pellet containing the cell debris (including the bacterial 
chromosome) was removed and the plasmid DNA was precipitated by the addition of 200µl 
of isopropanol and centrifugation for 5 min at 12,000g. The pellet was then washed in 70% 
ethanol, air-dried for 10 min and resuspended in l00µ1 TE buffer. Typical yields of 1-5µg 
plasmid DNA are obtained via this method. 
2.3.7 Restriction enzyme digestion analysis of plasmid DNA 
0.1-1µg of DNA was usually digested with lgl of appropriate restriction enzyme, according 
to the manufacturers instructions. All restriction enzymes were obtained commercially from 
New England Biolabs and digests were performed in a 2Oµ1 volume of lx appropriate 
manufacturer's enzyme buffer for lh at 37°C. For analysis, half the digest was added to 1µl 
10x DNA loading buffer and DNA fragments separated on TBE agarose gels. 
2.3.8 Gel purification of DNA fragments 
DNA fragments were separated on 0.8% TBE/agarose gels and the relevant bands excised. 
DNA was purified from the gel bands using the QlAquick Gel Extraction Kit (Qiagen Ltd). 
In brief, gel slices were melted in a buffer containing guanidine thiocyanate. This chelates 
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the water, forcing the DNA to bind to a silica resin contained in a gravity-flow column. 
Columns were then ethanol washed before elution with TE buffer. 
2.3.9 Ligations - oligonucleotide insertion 
For the creation of double stranded oligonucleotides, 0.1µg of each strand of the 
oligonucleotides were annealed at 60°C for Ih in a volume of 20µl of lx T4 DNA ligase 
buffer (New England Biolabs). 
For the insertion of the double-stranded oligonucleotide into the vector, the following 
ligation reactions were set up: 
Vector (V) Oligo (0) lOx ligase buffer ddHZO Molar Ratio (O: V) 
1.5µ1 - lµl 6.8µl - 
1.5µ1 3µl lµl 3.5µ1 approx. 50: 1 
1.5µl 6µl 1 tI 0.5µl approx. 100: 1 
0.2µl of T4 DNA ligase (New England Biolabs) was added to each ligation reaction, and 
incubated at room temperature for 2h. 
2.3.10 Ligations - standard reaction 
For ligation of larger fragments of DNA into vectors, 20 µl reactions were set up as for 
oligonucleotide insertion, but with molar ratios of 2: 1 and 10: 1 (insert: vector) used instead. 
2.3.11 Transformation of bacteria 
TOP1OTM chemically competent Escherichia coli (Invitrogen) were transformed as per the 
manufacturer's instructions. 50µl of transformed cells were spread onto LB agar plates 
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containing the appropriate selective antibiotic (100µg/ml ampicillin unless stated 
otherwise). Single transformed colonies were picked using a sterile loop and inoculated 
into L-Broth with appropriate selection. Cultures were shaken at 37°C, 250rpm, in a tube 
or flask at least 4 times the volume of the culture to ensure good aeration. 
2.3.12 Sequencing and analysis of DNA 
PCR fragments were purified away from the PCR reaction using spin columns (S400, 
Amersham Pharmacia Biotech), according to the manufacturer's instructions. 1µg plasmid 
DNA or 5µg PCR product was sent to MWG Biotech Ltd for sequencing. The resulting 
sequencing data was analysed using Lasergene software (DNAStar). 
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2.3.13 Oligonucleotides 
The following oligonucleotides were used in this thesis: 
Oligo Name Use Sequence (5'-3') 
Xhol 5' GFP Primer for the amplification of GFP GGA CGG AGA AGA 
from pDNeoGFP, adds a 5' XhoI TGC TCG AGC TTG 
site for insertion into pDXA-3C-aar CAT GCC CAT GAG 
XbaI 3' GFP Primer for the amplification of GFP CGA GCT CGA GAT 
from pDNeoGFP, adds a 3' XbaI CTA GAT ATC GAT 
site for insertion into pDXA-3C-aar GAA TTC GAG 
aar 5' KpnI ýN201 5' primer for the creation of Aar GGT ACC TTA GAA 
AN201, used with `aar 3' Xho1'. GGT ATA GAA GAT 
Adds 5' KpnI site for insertion into CAA AAC G 
DXA-3C. 
aar 5' ATG KpnI AN258 5' primer for the creation of Aar GGG TAC CAA AAA 
AN258, used with `aar 3' XhoI'. TGG GTA GCA CTA 
Adds 5' KpnI site, (followed by ATA ACC ACA ACA 
ATG for insertion into pDXA-3C. AC 
aar 5' ATG KpnI i N371 5' primer for the creation of Aar GGG TAC CAA AAA 
AN371, used with `aar 3' XhoI'. TGT CAA GAT GGT 
Adds 5' KpnI site, (followed by CAA ATC CAA C 
ATG) for insertion into pDXA-3C. 
aar 5' ATG KpnI AN587 5' primer for the creation of Aar GGG TAC CAA AAA 
AN587, used with `aar 3' XhoI'. TGA GTG CAA AAG 
Adds 5' KpnI site, (followed by AAG GTG 
ATG) for insertion into pDXA-3C. 
aar 3' XhoI 3' primer used with 5' Aar, &N ATA ACT CGA GTT 
primers. Adds 3' Xhol site for CCA TCT TCT AAT 
insertion into DXA-3C-aar GCT ACT TG 
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Oligo Name Use Sequence 
aar 5' KpnI 5' primer used with 3' Aar AC GTC CTA ATG GTA 
primers. Adds 5' KpnI site for CCT ACC ACA CCA 
insertion into pDXA-3C-aar CAC ACC C 
aar 3' Xhol AC210 3' primer for the creation of Aar CTG ACT CGA GCA 
AC210, used with `aar 5' Kpnl'. TCG TTT TGA TCT 
Adds 3' XhoI site, for insertion into TCT ATA CCT TC 
DXA-3C. 
aar 3' XhoI AC288 3' primer for the creation of Aar GAT TCT CGA GCA 
AC288, used with `aar 5' KpnI'. TTA TTA CTA CTT 
Adds 3' XhoI site, for insertion into TCA ATT AAA TTA 
pDXA-3C. C 
aar AC623 up Upper strand oligo of a pair. AAT TCA AAC ACA 
Annealed with `aar AC623 down' AGG TTG TGG TGC 
to make a double-stranded CCT AAG AAA TTT 
oligonucleotide, used to replace the AGG TTG TAG 
sequence between the EcoRI and 
XhoI sites of pDXA-3C-aar to 
create Aar AC623. 
aar AC623 down See `aar AC623 up'. TCG ACT ACA ACC 
TAA ATT TCT TAG 
GGC ACC ACA ACC 
TTG TGT TTG 
aar V5His up Upper strand oligo of a pair. TCG AGA TGC ATT 
Annealed with `aar V5His down' to AGG TAA ACC AAT 
make a double-stranded TCC AAA TCC ACT 
oligonucleotide with a 5' XhoI site TCT TGG TCT TGA 
and a 3' XbaI site. Inserted into TTC AAC TCA TCA 
pDXA-3C-aar to create pDXA-aar- TCA TCA TCA TCA 
V5-his. TTA AT 
aar V5His down See `aar V5His up'. CTA GAT TAA TGA 
TGA TGA TGA TGA 
TGA GTT GAA TCA 
AGA CCA AGA AGT 
GGA TTT GGA ATT 
GGT TTA CCT AAT 
GCA TC 
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2.3.14 RNA hybridisation - northern analysis 
2-5x10' Dictyostelium cells were placed on dry ice. They were lysed immediately by 
adding 500µl of RNA buffer containing 1% SDS (v/v) and 500µ1 of phenol and then 
vortexing. In addition, the lysate was shaken for 15 min at room temperature. The mixture 
was cooled on ice before spinning at 20,000g, 15 min, 4°C to separate aqueous and phenol 
layers. 350µ1 of the aqueous layer was removed and transferred to 500µ1 chloroform, the 
mixture was vortexed, spun as above and the upper aqueous layer transferred to lml 
ethanol. RNA was precipitated for 1 hour at -20°C before spinning at 20,000g for 10 min, 
4°C. The pellet was washed in 70% ethanol, left to air dry on ice, and dissolved in 20µl 
sterile ddHZO. RNA concentration was determined by measuring the OD at A260 on a 
spectrophotometer. RNA was prepared for electrophoresis in 1x MOPS buffer, 0.2M 
formaldehyde, 50% (v/v) formamide and 10% (v/v) sterile RNA loading dye, denatured at 
60°C for 15 min and cooled on ice. 5µg RNA per lane was loaded on a 1% (w/v) agarose 
gel containing lx MOPS buffer, 0.65M formaldehyde and ethidium bromide to a final 
concentration of 0.25pg/ml. 
The gel was run in lx MOPS buffer at 120V for 3.5 hours. After electrophoresis, RNA was 
visualised under UV light and photographed before equilibrating in 10xSSC (see section 
2.6 for recipe) and blotting onto Hybond N nylon membrane (Amersham Pharmacia 
Biotech) by capillary transfer in 1OxSSC. The RNA was UV-crosslinked to the membrane 
(Stratalinker, Stratagene). 
Filters were prehybridised at 42°C for 5 hours in RNA hybridisation buffer and then 
hybridised in denatured probe. Aar, D19, or Ig7 PCR products, were labelled with [a-32P1 
dATP using the Megaprime DNA labelling kit (Amersham Pharmacia Biotech). 
Unicorporated nucleotides were removed by purifying the probe on MicroSpinTM S-400 HR 
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columns (Amersham Pharmacia Biotech). The purified probes were denatured by boiling 
for 5 mins, before being added to RNA hybridisation buffer, and incubated with filters 
overnight at 42°C. Unbound probe was removed with 2xSSC/0.1%SDS washes (2x 15 
minutes), followed by 0.5xSSC/0.1%SDS (2x 15 minutes). Filters were sealed in plastic 
and exposed against a phosphorimaging screen (K-Screen, Kodak), before imaging in 
BioRad phosphorimager. Band intensities were quantified, where desired, using the 
Quantity OneTM software (BioRad). 
2.4 Biochemistry 
2.4.1 Protein separation and western blotting of whole cell extracts 
Approximately lx 107 logarithmically growing cells were pelleted at 2,000g for 2 min. 
Sodium dodecyl sulphate-polyacrylamide gel electrophersis (SDS-PAGE) was used to 
separate proteins for western blotting. Cells were lysed by boiling for 5 min in Laemmli 
buffer and debris pelleted at 20,000g for 5 min before loading on a polyacrylamide gel. 
Between 105 and 106 cell equivalents per lane were loaded on to a discontinuous gel 
composed of a 4% polyacrylamide stacking gel, on top of either a 8.0% or 10% 
polyacrylamide resolving gel (Protogel, National Diagnostics Corporation), according to 
the range of size separation required. 
Electrophoresis was at 150V for 1.5 hours, and coloured molecular weight standards 
(Rainbow markers, Amersham Pharmacia Biotech) were run alongside samples for size 
determination. After electrophoresis, some gels were stained with Coomassie Blue 
overnight and destained over several hours with 4-5 changes of destain to visualise total 
protein. All other gels were equilibrated in western transfer buffer for 10 minutes. 
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Protein was electrophoretically transferred from gels to Hybond C-extra nitrocellulose 
membrane (Amersham Pharmacia Biotech) by semi-dry blotting in a BioRad transfer cell 
according to the manufacturer's instructions. The membrane was rinsed in phosphate 
buffered saline (PBS) and proteins were visualised using 2% PonceauS (w/v) in I% acetic 
acid (v/v) to ensure even transfer and loading. Membranes were blocked for 1 hour at room 
temperature or overnight at 4°C in 5% dried skimmed milk (w/v), 0.1% Tween-20 (v/v) in 
PBS. After five 5 minute washes in PBS/0.1% Tween-20 (v/v) (PBST) membranes were 
incubated in primary antibody diluted in PBST for 1-2 hours at room temperature. (Anti-V5 
was HRP tagged. All other antibodies required incubation with an HRP-conjugated 
secondary antibody. ) After incubation with primary antibody, filters were washed 
extensively in a large volume of PBST and incubated in secondary antibody diluted in 
PBST for a further hour. After further washes, the secondary antibody was detected using 
enhanced chemoiluminescence reagent (ECL, Pierce) according to the manufacturer's 
instructions. Protein bands were detected in a BioRad FluorSMax fluorimager. 
2.4.2 Antisera : The following antibodies were used during the course of this work: 
Primary 
" Aar: Rabbit polyclonal IgG, raised to a synthetic Aar peptide representing the final 5 
armadillo repeats of the protein. Used at 1: 1,000 for immunofluorescent cell staining, 
following testing of both the preimmune and immune sera at 1: 50,1: 100,1: 500 and 
1: 1,000 (the titration of the antisera was performed previously by Juliet Coates, in the 
lab - see also Coates, 1999). 
" GFP: Rabbit polyclonal IgG which recognises the epitope corresponding to amino 
acids 1-238 of green fluorescent protein (GFP) of Aequorea victoria. Used at 1: 1,000 
for western blotting. (Santa Cruz). 
9 V5: Mouse monoclonal IgG, which recognises the V5 epitope (GKPIPNPLLGLDST). 
Used at 1: 5,000 for western blotting. (Invitrogen). 
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" Ubiquitin: Rabbit polyclonal IgG. Used at 1: 100 for western blotting. (Sigma-Aldrich). 
Secondary 
9 Anti-Rabbit IgG (H+L). Horseradish peroxidase-conjugated antibody, raised in goats. 
Used at 1: 10,000 for western bloating. Vector Laboratories. 
2.4.3 Fast Protein Liquid Chromatography - FPLC 
An Amersham Pharmacia Biotech FPLC system was used for the size separation of protein 
samples. 0.25-0.5m1 of sample was loaded onto a SuperoseTM 12 column (Amersham 
Pharmacia Biotech) and washed with a solution of 50mM Tris/lOOmM NaCI (pH8.0). 
Samples were eluted with a flow rate of 0.25ml/min, and collected into 50µ1 of kinase 
protection buffer (see section 2.6). The apparent molecular weight of the proteins contained 
in each fraction was established from the standard curve previously generated in our 
laboratory by W. J. Ryves. 
2.4.4 Purification of peptides 
All peptides were synthesised commercially by Zinser Analytic and purified as follows. 
C 18 Sep-Pak Cartridges@ (Waters) were washed with 5m1 of acetonitrile, followed by 5ml 
ddH2O. Peptides were resuspended in 5m1 ddH2O before loading on the cartridges. 
Cartridges were then washed with 5ml ddH2O, before elution of peptide in 5ml 60% MeOH 
(v/v). Peptides were then dried down in a speed vac and re-suspended in the desired volume 
of ddH2O. 
2.4.5 In Vitro kinase assays 
In vitro kinase assays were performed as described before (Ryves et al., 1998). 5mUnits of 
recombinant GSK-30 (Upstate), 40 units of recombinant casein kinase 18 (New England 
Biolabs), or FPLC-purified Aark (as stated in the text) were added to each assay. In 
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addition, where indicated, lithium chloride was used at 50mM, and the casein kinase 1 
inhibitor CKI-7 (Seikagaku Corporation) was used at 10µM. 
Each assay was initiated by the addition of an ATP/Mg2+ mix (100µM final concentration), 
containing 4.625MBq/ml [y-32P] ATP. After 10 minutes had elapsed, the peptide was 
immobilised on P81 cellulose phosphate paper (Whatman), by spotting 2Oµ1 of each assay 
onto squares of the paper. The P81 squares were then washed 3 times in 100mM 
phosphoric acid to remove the unincorporated radioactive phosphate. The papers were 
washed for a total of lhour, and the activity of each square counted in a beta counter (Tri- 
Carb 1900 TR, Packard). In addition to counting the activity of each individual assay, an 
equivalent quantity of ATP/Mg2+/['y-32P] ATP as was used in the assay was also counted to 
enable the determination of the amount of phosphate transferred as a ratio of the amount 
added. 
2.5 Cell biology 
2.5.1 Development of Dictyostelium 
Cells were spun down from logarithmically growing culture (1-2x106 cells/ml) and washed 
four times in KK2. Cells were resuspended in 300µl of KK2 and spread evenly across black, 
nitrocellulose filters (4.7cm diameter, 0.45µm pore size, Millipore) on a KK2 -soaked pre- 
filter. Filters were incubated at 22°C in a humid atmosphere for the required length of time. 
2.5.2 Immunofuorescent cell staining 
Vegetative cells were allowed to settle on glass coverslips (BDH). To fix cells, the media 
was removed and replaced with 200µl 0.1% paraformaldehyde (w/v) in picric acid (pH6.5) 
for 30 minutes. Cells were then washed in the following sequence: 10mM PIPES, 
PBS/glycin (twice), 70% ethanol, and 100mM PBS/glycin (three times). Cells were 
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blocked against non-specific binding in PBG (see section 2.6 for recipe), for 15 minutes. 
Antibodies were diluted as above, in blocking reagent. After incubation with primary 
antibody for 2-3hours at room temperature, cells were washed 7 times in blocking solution, 
before incubation with secondary antibody for 1-2 hours at room temperature. Cells were 
then washed in the following sequence PBG, 100mM PBS/glycin (three times), and finally 
once in ddHZO before mounting with mowial mountant. Slides were viewed on a Bio-Rad 
MRC1024 confocal microscope. 
2.5.3 Live cell imaging of GFP transformants 
`Hanging drop' slides were made as follows: a rubber `0' ring, approximately 2cm in 
diameter, was greased and placed on a glass coverslip. 0.5ml of log phase culture was spun 
out of media and washed once in KK2 buffer, before resuspension in 5%Ll of KK2 +/- 
inhibitor: 10mM LiCL, or 10µM of the specific IMPase inhibitor L-690,330 (Tocris 
Cookson). Cells were then pippetted into the middle of the `0' ring and allowed to settle 
before 25µ1 of the liquid was removed. A glass slide was placed on top of the `0' ring with 
sufficient pressure as to create a seal between the coverslip, `0' ring and slide. The slide 
was then inverted, thus producing a `hanging drop', ready for viewing on a Bio-Rad 
MRC1024 confocal microscope. 
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2.6 Inhibitors 
The following inhibitors were used during the course of this work: 
" CKI-7 (casein kinase 1 inhibitor): purchased from Seikagaku Corporation; 10mM 
stock solution (in DMSO); added as 1/4 part to in vitro kinase assays (see section 2.4.5) 
at 10µM final concentration (the manufacturers quote an IC50 value of 9.54M). 
" L-690,330 (IMPase inhibitor): purchased from Tocris Cookson; 100mM stock 
solution (in ddH2O); used at 10µM. L-690,330 has an IC50 value of 1µM (Klein and 
Melton, 1996). L-690,330 was used at 10µM (following titration experiments 
performed previously by R. Williams in the lab). The inhibitor was added to the KK2 
cell suspension during live cell imaging of GFP transformants. 
" SB-415286 (GSK-3 inhibitor): a kind gift from GlaxoSmithkline; 2mM stock solution 
(in DMSO); added as 1/4 part to in vitro kinase assays (see section 2.4.5) at 1µM final 
concentration. The inhibitor has a K; value of 31 nM, but was titrated into a standard 
assay to determine the optimum concentration for the level of ATP used in these assays, 
since it is a direct competitor of ATP (this was previously performed by W. J. Ryves). 
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2.6 Recipes and reagents 
Standard laboratory chemicals were from BDH. Other chemicals were from Sigma 
Chemical Company unless otherwise stated. All chemicals were reagent grade or better. 
Media 
Axenic medium 
" 1.43% peptone (w/v) (Oxoid, L34) 
" 0.72% yeast extract (w/v) (Oxoid L21) 
" 3.6mM Na2HPO4,3mM KH2PO4 
" 30% glucose (w/v) 
" 0.5mg/ml vitamin B 12,1mg/ml folic acid pH9.0 
Final pH 6.4 (sterile) 
KIEZ 
" 15.5mM KH2PO4 
" 3.8mM K2BPO4 
" Final pH 6.2 
L-Broth 
9 1% bactotryptone (w/v) (Difco) 
" 0.5% bacto-yeast extract (w/v) (Difco) 
" 17mM NaCl 
Final pH 7.0 (sterile) 
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LB agar 
" L-broth 
" 1.5% Bactoagar (w/v) (Difco) 
SM (Sussman's medium) 
"1% glucose (w/v) 
" 1% peptone (w/v) (Oxoid L34) 
" 0.1% yeast extract (w/v) (Oxoid L21) 
" 2% agar (w/v) (Difco) 
" 4mM MgSO4,4mM KH2PO4,6mM K2HPO4 
Molecular Biology 
50x Denhardt's solution 
" 1% BSA (w/v) (FractionV) 
91% Ficoll (w/v) 
" 1% Polyvinylpyrollidine (w/v) 
DNA loading buffer 
" 0.25% bromophenol blue (w/v) 
" 0.5% xylene cyanol (w/v) 
" 15% Ficoll-400 (w/v) 
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MOPS buffer 
9 20mM MOPS pH7.0 
" 5mM Na Acetate 
"1 mM EDTA 
RNA buffer 
" 100mM Tris-HC1, pH 7.4 
9 200mM NaCl, 
" 20mM EDTA 
RNA hybridisation buffer 
" 43% formamide (v/v) 
" 5x SSC 
" lOx Denhardt's solution 
" 10mM Na2HPO4/NaH2PO4 pH 6.8 
" 200mg/ml denatured, sheared salmon testis DNA 
" 0.1 % SDS (v/v) 
RNA loading dye 
" 50% glycerol (v/v) 
" 1mM EDTA 
" 0.4% bromophenol blue (w/v) 
" 0.4% xylene cyanol (w/v) 
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ssc 
9 150mM NaCl 
9 15mM Na3citrate 
STET 
" 50mM Tris-HC1 pH8 
9 50mM EDTA 
" 8% sucrose (w/v) 
0 5% Triton-X 100 (v/v) 
0.5x TBE 
" 45mM Tris-HC1 
" 45mM Boric acid 
0 1mM EDTA 
TE 
9 10mM Tris-HCI pH 7.4 
"1 mM EDTA 
69 
Biochemistry 
Coomassie destain 
1 25% methanol (v/v) 
2 16% acetic acid (v/v) 
Coomassie stain 
" 0.25% Coomassie Brilliant Blue (v/v) 
" 10% acetic acid (v/v) 
" 45% methanol (v/v) 
6x Kinase Protection Buffer 
" 50mM Tris (pH7.4) 
" 100µM EGTA 
" 5OmM NaC1 
" 50% glycerol (v/v) 
" 1mM AEBSF 
" 1mM benzamidine 
" 1OmM DTT 
Laemmli buffer 
" 10% glycerol (v/v) 
" 100mM DTT 
" 2% SDS (v/v) 
" 50mM Tris-HC1 pH6.8 
" 0.1 % bromophenol blue (w/v) 
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PBS 
" 137mM NaCl 
" 2.68mM KCl 
9 7.98mM Na2HPO4 
9 1.47mM KH2PO4 
Final pH 7.2 
Tris Kinase Buffer (TKB) 
" 20mM Tris 
" 2mM DTT 
" pH 7.5 
" Western transfer buffer 
" 48mM Tris 
" 39mM glycine 
" 20% methanol 
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Cell Biology 
Mowial mountant 
" 2.4g MOWIAL 
" 6g glycerol 
Add 6m1 ddH2O and stir for several h at RT. 
Add 12m1 0.2M Tris, pH8.5 and heat to 50°C 
Add 2.5% DABCO (w/v) 
PBG 
In 1L PBS: 
" 5g BSA 
" Ig fish gelatin 
Sterile filter. 
PBS/Glycin 
" 500m1 PBS 
" 3.75g glycin 
Sterile filter. 
Picric acid 
" 0.4g paraformaldehyde 
" 5ml ddH2O 
"3 drops 1M NaOH, heat to 40°C and make up to 7m1 before adding: 
" 10m120mM PIPES 
" 3m1 saturated picric acid solution 
Final pH 6.5 
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Chapter 3 
Phosphorylation of Aardvark 
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3.1 Introduction 
Aardvark (Aar) possesses signalling functions known to be dependent on the activity of the 
Dictyostelium GSK-3 homologue, GskA (Grimson et al., 2000; Fraser et al., 2002). GSK-3 
phosphorylation of ß-catenin targets the protein for breakdown following the binding of the 
F-box protein 1 Trcp. In C. elegans however, the relationship between GSK-3 and the (3- 
catenin homologue WRM-1 appears to be a positive one (Korswagen et al., 2000). This 
also appears to be the case in Dictyostelium (Grimson et al., 2000), but it has yet to be 
established whether the interaction between GskA and Aar is a direct one. Therefore, one of 
the aims at the outset of this project was to determine whether GskA phosphorylates Aar. 
3.2 Establishing an in vitro kinase assay for GSK-3 phosphorylation of ß-catenin 
peptides 
The study of (3-catenin phosphorylation in vivo is complex: it requires either the over- 
expression of a dominant negative form of ßTrcp, or the addition of proteosome inhibitors 
(Amit et al., 2002). GSK-3 will only phosphorylate f3-catenin at low levels in vitro (Yost et 
al., 1996). Both priming phosphorylation by Casein Kinase la (CK1a) and the addition of 
other protein factors such as Axin, are required (Hagen and Vidal-Puig, 2002; Amit et al., 
2002; Liu et al., 2002). 
In vitro GSK-3 kinase assays utilising peptide substrates have previously been reported 
(Wang et al., 1994; Ryves et al., 1998; Ginger et al., 2000). To establish whether this 
approach would work for a known GSK-3/0-catenin interaction, peptides based upon the 
N-terminal GSK-3 target sites of ß-catenin, encompassing Ser-33, Ser-37, Thr-41 and Ser- 
45, were commercially synthesised. Two peptides were made, corresponding to amino 
acids 24 to 49 of ß-catenin. One peptide was synthesised with the priming phosphate on 
Ser-45. Both peptides (and all future peptides) had the addition of two N-terminal and three 
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C-terminal Arg residues. This was to facilitate the binding of the peptides to P81 cation 
exchange cellulose phosphate paper, in the in vitro kinase assays (see section 2.4.5). Figure 
3.1 outlines the sequence of the two peptides and also shows the site at the N-terminus of 
the protein from where the peptides were derived. 
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Peptide name Sequence 
n-UP RRHWQQQSYLDSGIHSGATTTAPSLSGKRRR 
ß-P1 RRHWQQQSYLDSGIHSGATTTA SGKRRR 
Aar-UP RRSNYSSPNTLIPSVSKTYISPFRRR 
Aar-P1 RRSNYSSPNTLIPSVS ISPFRRR 
Aar-P2 CRRSNYSSPNTLI SKTYISPFRRR 
Figure 3.1 Comparison of ß-catenin and Aar proteins and peptide substrates 
(a) Alignment of ß-catenin and Aardvark proteins, based upon the shared homology of their 
Arm domains, GSK-3 phosphorylation sites (black oval) and a-catenin binding sites (red 
star). The GSK-3 sites and a-catenin binding site of Aardvark are putative. Residues in red 
represent the known/putative phosphate-accepting residues and the priming sites are boxed 
and marked P1 or P2. 
(b) Sequences of Aardvark and ß-catenin peptides. All peptides possess two N-terminal and 
three C-terminal Arg residues to facilitate binding to the cellulose phosphate paper in the in 
vitro kinase assay. Red residues represent the Ser/Thr residues to receive the phosphate. UP 
= unprimed; P1 = primed, position 1; P2 = primed, position 2. 
76 
23 Pi 49 
HWQQQSYLDSGIHSGATTTAPSLSGKG R_ýatcinin 
233 P2 P1 253 
SNYSSPNTLIPIJSK [ISPF 
3.3 GSK-30 phosphorylates a phosphate-primed ß-catenin peptide in vitro 
Recombinant GSK-30 was unable to phosphorylate the un-primed ß-catenin peptide (ß-UP) 
in the in vitro kinase assay (see section 2.4.5). However, the addition of the priming 
phosphate at Ser-45 (producing 1-P1) created a GSK-3 substrate (figure 3.2). Furthermore, 
the addition of 50mM lithium chloride (LiCI), to inhibit the kinase activity of GSK-30, 
reduced activity towards the peptide by almost 90%. 
The Michaelis constant, K.  of an enzyme is calculated by measuring the activity 
from a 
range of substrate concentrations, and creating a double reciprocal plot of velocity versus 
substrate concentration, known as the Lineweaver-Burke plot. The intercept on the 
horizontal axis represents -1/Km. 
To calculate the K. value for the interaction between GSK-30 and ß-P1, an in vitro kinase 
assay was performed with GSK-30 and serial dilutions of 200µM ß-P1. Figure 3.3 (a) and 
(b) show the activity of GSK-30 towards each dilution of ß-P1, and the resultant 
Lineweaver-Burk plot is shown in (c). The K. value was calculated from the plot, using 
Excel software (Microsoft), to be 85µM. This value falls within the range of Km values for 
known GSK-30 peptide substrates, for example CREB, 200µM (Wang et al., 1994); the 
modified glycogen synthase peptide GSM, 75µM (Ryves et al., 1998); and DdSTATa, 
25µM (Ginger et al., 2000). 
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Figure 3.2 GSK-3(3 phosphorylation of P-catenin peptides 
Activity of recombinant GSK-3(3 towards (3-catenin-UP (n-UP), and (3-catenin-PI 
((3-PI ) peptides in an in vitro kinase assay. Lithium chloride was added to the assay, 
as indicated, at 50mM to inhibit the kinase activity of GSK-3(3. The ist columns (grey) 
represent peptides at 400µM; the 2nd columns (black) represent peptides at 800µM. 
The assay was performed in triplicate, and the results are shown +/- SEM. 
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Figure 3.3 Calculating the Km value for GSK-3p phosphorylation of ß-P1 
a) Phosphorylation of 200µM 13-P 1 by GSK-30 
b) Serial dilutions of (3-P l from 200µM to 3. l 25µM 
c) Double-reciprocal plot of GSK-3ß activity against ß-P1. Km value = 85µM 
0= BP = linear BP. The assay was performed in triplicate. Results 
are shown +/- SEM. 
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3.4 Aar peptide substrates and GSK-30 
When the Arm repeat domains of Aar and ß-catenin are aligned, a site in the N-terminal 
region of Aar containing four Ser/Thr residues, conforming to the GSK-3 consensus 
phosphorylation site, aligns with the N-terminal GSK-3 sites of (3-catenin (figure 3.1 & 
Grimson et al., 2000). Furthermore, at no other point along the length of the Aar protein are 
there 4 consecutive sites conforming to the GSK-3 consensus site. Peptides that spanned 
these putative GSK-3 sites of Aar (amino acids 233-253) were synthesised commercially, 
with or without a priming phosphate on a Thr residue at +4 to the start of the putative sites 
(Aar-P1 and Aar-UP, respectively; figure 3.1). In addition, a third peptide (Aar-P2) was 
synthesised which had the priming phosphate positioned on a Ser at -4 to the 
phosphorylated Thr in Aar-P1, to mimic phosphorylation by GSK-3. 
Recombinant GSK-30 did not phosphorylate any of the three Aardvark peptides in vitro 
(figure 3.4). To validate the experimental approach, assays were repeated, including the 
GSK-3 substrate, GSM, and electrophoresed on a 16% tricine gel. Whilst phosphorylation 
of GSM was detected, phosphorylation of the Aar peptides remained undetectable (figure 
3.4). 
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Figure 3.4 GSK-30 kinase activity towards Aar peptides 
(A) Recombinant GSK-3(3 was tested for activity towards the modified GSK-3 
peptide substrate, GSM, and towards all three Aar peptides in an in vitro kinase 
assay. No phosphorylation of the unprimed Aar peptide (Aar-UP) or the two 
primed peptides (Aar-PI and Aar-P2) was detectable. GSK-3(3 activity was 
inhibited with 50mM LiCI. The results of one triplicate assay are shown +/- SEM. 
(B) The assays in (a) were repeated, but stopped by the addition of SDS before 
separation of samples on a 16% tricine gel. Phosphorylation was detected by 
phosphorimaging. Whilst phosphorylation of GSM could be detected, there was 
no detectable phosphorylation of any of the Aar peptides. GSK-3(3 activity was 
inhibited with 50mM lithium chloride. The assay was repeated and the same 
results obtained. 
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3.5 Phosphorylation of Aar peptides by MC-purified Dictyostelium cell extracts 
GskA and GSK-30 share 71% sequence homology in their catalytic domain (Harwood et 
al., 1995) and GskA phosphorylates all tested GSK-30 substrates in vitro; for example, 
CREB, GS-1 and GSM (W. J. Ryves, pers. commun. ). Further, GSK-3(3 phosphorylates the 
GskA substrate DdSTATa in vitro. However, this does not preclude that Aar is a substrate 
for GskA but not GSK-30 in vitro. The availability of a gskA null Dictyostelium strain aids 
the determination of whether any activity towards Aar comes from GskA or another kinase. 
GskA is active throughout growth and development (Plyte et al., 1999). A Dictyostelium 
growth phase cell extract was separated by FPLC on the basis of charge and the fraction 
exhibiting peak GskA activity was determined by its activity towards GSM (this work was 
previously performed by W. J. Ryves in the lab). This peak fraction was used to determine 
whether GskA exhibited kinase activity towards any of the three Aar peptides. As cell 
extracts and not purified kinases were being used, the use of lithium to inhibit GSK activity 
was inappropriate due to a second lithium target, IMPase, being present. Therefore, the 
GSK-3 inhibitor, SB-415286, was added at lp. M to specifically inhibit GskA activity. 
Figure 3.5 shows the levels of GskA phosphorylation of the three Aar peptides. Partly- 
purified GskA phosphorylated Aar-P1 to a level four-fold higher than with the unprimed 
peptide, which itself was higher than the Aar-P2 phosphorylation. This phosphorylation of 
Aar is therefore dependent on priming and, in addition, the positioning of the priming 
phosphate is critical. However, the addition of SB-415286 reduced the observed activity 
towards Aar-P1 by 20%, whereas it reduced phosphorylation of GSM by 59%. This 
suggested that a kinase other than GskA (later termed Aark for `Aar kinase') was 
responsible for phosphorylation of Aar-Pl. Further investigation of the biochemical 
characteristics and identity of Aark were subsequently initiated. 
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Figure 3.5 GskA phosphorylation of Aar peptides 
Activity of a FPLC-purified sample, containing peak kinase activity for GskA, 
against Aar-UP (UP), Aar-P1 (P1), Aar-P2 (P2) and GSM. All peptides were 
added at 400µM and SB-415286 (SB) was added at 1pM, where indicated. 
Although assayed alongside the Aar peptides, the GSM activity is shown 
separately for greater clarity. The assay was performed in triplicate and results 
are shown +/- SEM. 
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3.6 Further purification of Aark 
In order to separate Aark from GskA, a range of FPLC-purified gskA null cell extracts 
(provided by W. J. Ryves in the lab) were tested for activity towards the three Aar peptides 
(figure 3.6). The peak of Aark activity was detected in fraction number 15. This activity 
was priming-dependent, as the Aar-P1 peptide was phosphorylated to a three-fold higher 
level than Aar-UP. Furthermore, the precise site of the priming phosphate is critical, as a 
peptide with the priming phosphate moved to a position -4 from that of the original peptide 
was no longer a substrate. 
3.7 Determing the size of Aark and the K. value for its interaction with Aar-P1 
The peak gskA null fraction for Aark activity was subjected to further FPLC separation both 
to estimate the size of Aark and determine the K. value for its interaction with Aar-P1. The 
peak Aark fraction was passed through a size gradient column (see section 2.4.3). Prior 
calibration of the system with molecular weight standards allowed the determination of the 
approximate molecular weight of each resulting fraction. Figure 3.7 shows the activity of 
the resulting fractions towards Aar-P1. The peak of Aark activity is in the apparent size 
range of 30-35kDa. 
To calculate the K. value for the interaction between Aark and Aar-P1, serial dilutions of 
3.2mM Aar-P1 were made and an in vitro kinase assay performed with the newly-purified 
Aark. Figures 3.8 (a) and (b) show the activity of Aark towards each dilution of Aar-P1, 
and the Lineweaver-Burk plot is shown in (c). The K. value was calculated from the plot to 
be 365µM. 
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Figure 3.6 Activity of purified gskA null fractions against Aar peptides 
Proteins from a gskA null Dictyostelium cell extract were separated by FPLC, on 
the basis of ion exchange and interaction with phosphocellulose. This separation 
was via aP 11 phosphocellulose exchange column (Whatman), across a 0-500mM 
NaCl gradient (this purification was performed by W. J. Ryves in the lab). The 
resulting fractions were assayed for activity towards each of the Aar peptides by 
in vitro kinase assay. 
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Figure 3.7 Activity of size-separated FPLC gskA null fractions against Aar-P1 
Proteins from a Dictyostelium gskA null cell extract were separated by FPLC, on the 
basis of size, through a Superose 12 column. The system was previously calibrated 
with molecular weight markers, which allowed an estimate of the size of Aark to be 
made. The fraction which corresponded to 30-35kDa showed peak Aark activity, as 
determined by activity towards Aar-P1 in an in vitro kinase assay. 
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Figure 3.8 Calculating the Km value for Aark phosphorylation of Aar-P1 
a) Phosphorylation of 3.2mM Aar-P I by Aark 
b) Serial dilutions of Aar-PI from 3.2mM down to 200µM 
C) Double-reciprocal plot of Aark activity against [Aar-P I I. Km value = 
305µM 
 = Aar-PI = linear Aar-P1. The assay was performed 
in triplicate. 
Results are shown +/- SEM. 
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3.8 Aark shows specific activity towards Aar 
Having shown that recombinant GSK-3ß shows specific activity towards the phosphate- 
primed ß-catenin peptide but not to either of the phosphate-primed Aar peptides, it was 
important to determine whether the reverse was true for Aark. Aark shows no activity 
towards either the un-primed or primed ß-catenin peptides (figure 3.9). This shows that 
Aark phosphorylation of Aar-P1 is specific for this phosphopeptide. 
r 
3.9 Determining the identity of Aark 
It has already been established that Aark requires Aar to be phosphate-primed. Besides the 
GSK-3 family of Ser/Thr protein kinases, the Casein Kinase 1 (CK1) family are the only 
other group of protein kinases known to show a preference for primed substrates. CK1 
recognises the sequence S/T(Phos)-X-X-SIT, putting the phosphate onto a Ser or Thr 
residue at +3 to the priming phosphate. 
CKI-7, N-(2-aminoethyl)-5-chloroisoquinoline 8-sulfonamide, exerts potent inhibition of 
CK1 with an IC50 value of 9.5µM (Seikagaku Corporation). CKI-7 causes only weak 
inhibition of protein kinase C at 1mM, and has an IC50 value of 550µM for cAMP- 
dependent protein kinase. The high specificity of CKI-7 inhibition of CK1, along with the 
commercially available recombinant CK1 and its cognate peptide substrate provide 
excellent tools to determine whether Aark is a CK1 family member. 
The ability of CKI-7 to inhibit Aark phosphorylation of Aar-P1 and the ability of 
recombinant CK1 to phosphorylate Aar-P1 were tested (figure 3.10). Aark was unable to 
phosphorylate the CK1 peptide substrate (CK1-P), but CKI-7 (10µM) reduced the activity 
of Aark towards Aar-P1 by 45%. However, CKI was unable to phosphorylate Aar-P1, 
whilst CKI-7 reduced CK1 activity towards the CK1 peptide by almost 80%. 
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Figure 3.9 Comparison of Aark activity towards Aar and (3-catenin peptides 
400µM Aar-PI (P1), ß-catenin-UP ((3-UP) and ß-catenin-PI (ß-P1) were all added 
alone or with Aark in an in vitro kinase assay. The results shown are from one assay 
performed in triplicate, +/- SEM. The assay was repeated, with the same trend seen. 
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Figure 3.10 Aark and CKI phosphorylation of Aar and CKIP peptides 
All peptides were added at 400µM in the in vitro kinase assay. UP = Aar-UP; Pl = Aar-P1; 
CKIP = Casein Kinase 1 peptide substrate. The CK I inhibitor, CKI-7, was used at 10µM, 
where indicated. The results of one assay, performed in triplicate, are shown +/- SEM. 
The assay was repeated and the same trends seen. 
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3.10 Determining the recognition site for Aark 
Aark is a Dictyostelium protein kinase that requires some, or all, of its substrate to be 
phosphate-primed. To aid in the identification of Aark, the substrate recognition sequence 
was determined. This would also determine whether Aark is a tyrosine or a serine/threonine 
specific protein kinase. 
Shortened Aar-P1 peptides (with the prefix `S') were designed, and substitutions of each of 
the serine, threonine or tyrosine candidates for phosphate-acceptors, were made (Table 3.1). 
Alanine and serine are two structurally similar amino acids. They differ in the fact that 
alanine posseses a methyl group instead of the phosphate-accepting hydroxyl group of 
serine on one of its side chains. Likewise, phenylalanine and tyrosine are structurally 
related, with the only difference being the absence of the phosphate-accepting hydroxyl 
group on the carbon ring of phenylalanine. Therefore the substitution of serine/threonine 
residues with alanine, or tyrosine residues with phenylalanine produces non- 
phosphorylatable residues that conserve the structure of the peptide and allows the 
comparison of phosphorylation efficiencies. 
Peptide Name Sequence 
Aar-P1 RRRSNYSSPNTLIPSVSKT(Phos)YISPFRR 
Aar-SP1 RRRLIPSVSKT(Phos)YISPFRR 
Aar-S2 RRRLIPAVSKT(Phos)YISPFRR 
Aar-S3 RRRLIPSVAKT(Phos)YISPFRR 
Aar-S4 RRRLIPSVSKT(Phos)FISPFRR 
Aar-S5 RRRLIPSVSKT(Phos)YIAPFRR 
Table 3.1 Sequences of new, shortened Aar peptides 
Sequences of the shorter Aar peptides compared with the original Aar-P1. Residues in red 
highlight the non-phosphorylatable substitutions. The sequence of the original Aar-P1 is 
included for comparison. 
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The ability of Aark to phosphorylate the new, shortened, peptides was tested (figure 3.11). 
A high degree of activity towards Aar-SP1 was seen, which showed that shortening the 
peptide by removing the first eight amino acids had no effect on the ability of Aark to 
phosphorylate it. At 400µM, Aar-S4 and Aar-S5 were phosphorylated to an equal level as 
Aar-SP1. This meant that the sites of their substitutions could not be the phosphate- 
accepting residues. This also confirms that Aark is a Ser/Thr kinase and not a tyrosine 
kinase, as the substitution contained in Aar-S4 has replaced the only tyrosine in the peptide. 
Aark showed low activity towards both Aar-S2 and Aar-S3, meaning that at least one (or 
both) of the substituted residues represents the phosphate-accepting residue(s). One 
explanation could be that one of the residues is the phosphate-accepting residue, whilst the 
other is required in a structural capacity to enhance the peptide-kinase interaction. To test 
this possibility, the assay was repeated with Aar-S2 and Aar-S3, but this time an 8-fold 
increase in peptide concentration was used. If ope of the serine residues is required to 
optimise the enzyme-substrate binding, then a large increase in peptide concentration might 
be able to overcome the block, whilst an increase in peptide concentration should have little 
effect on the peptide whose substitution represents the phosphate-accepting residue. For 
this experiment, the assay time was increased from 10 minutes to 30 minutes as an 
additional aid to enhance the kinetics of the reaction. The repeated assay is included in 
figure 3.11 to allow a direct comparison of the two peptide concentrations. Whilst the 
phosphorylation of both the Aar-SP1 control and Aar-S2 increased by greater than 400%, 
the phosphorylation of Aar-S3 increased only by about 50%, relative to the control. This 
suggests that the substituted serine residue in Aar-S3 is the phosphate acceptor, and that the 
substituted serine in Aar-S2 is required for the optimum substrate recognition site. This 
proposes a recognition site for Aark of S-X-J-X-T(Phos), with the highlighted serine being 
the phosphate acceptor. 
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Figure 3.11 Aark phosphorylation of shortened Aar peptides 
The ability of Aark to phosphorylate Aar peptides with alanine or phenylalanine substitutions, 
plus the original Aar-P 1 (P 1), was tested in an in vitro kinase assay. Grey columns represent 
activity towards 400gM peptides; black columns represent activity towards 3.2mM peptides 
in an extended, 30 minute, assay (only selected peptides were repeated at 3.2mM, see text for 
details). The results of a single assay, performed in triplicate are shown, +/- SEM. 
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3.11 Discussion 
A genetic interaction between GskA and Aardvark has previously been established 
(Grimson et al., 2000). It was originally the aim of this work to determine whether that 
interaction is a direct one, i. e. does GskA phosphorylate Aar? That question still remains 
unanswered, but in addressing this question, a novel priming-dependent Ser/Thr kinase that 
phosphorylates Aar in vitro was discovered. 
3.11.1 GSK-3 will phosphorylate an N-terminal ß-catenin peptide in vitro 
In vitro GSK-3 kinase assays, utilising peptide substrates, have previously been described 
(Ginger et al., 2000; Ryves et al., 1998; Wang et al., 1994). However, the use of ß-catenin 
peptides in GSK-3 assays has not been reported. The data presented here shows that GSK-3 
will phosphorylate an N-terminal ß-catenin peptide in vitro and, furthermore, this 
phosphorylation requires the peptide to be primed on Ser-45. The K. value for this 
interaction was established as 85µM. This figure falls within the range of values previously 
reported for GSK-3 peptide substrates. 
3.11.2 Is Aar a GSK-3 substrate? 
Peptides based on the putative GSK-3 phosphorylation sites of Aardvark were synthesised 
commercially, with and without a priming phosphate. These peptides were not substrates 
for GSK-3 in vitro. However, the possibility that GskA, but not GSK-3, would 
phosphorylate at these sites in vitro still remained. To address this, FPLC-purified 
Dictyostelium cell extracts with high levels of GskA activity were tested for activity 
towards the Aar peptides. Activity was observed, but the specific GSK-3 inhibitor, SB- 
415286 , reduced the activity by only about 20%. This suggested that the activity 
in the 
extracts was not due to GskA. 
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These experiments, however, can not exclude the possibility that GskA phosphorylates Aar 
protein in vivo. Additional potential GSK-3 phosphorylation sites are also present in the 
Aar sequence, within the Arm domain and also within the N-terminus. Like the N-terminal 
sites of ß-catenin, the GSK-3 sites in Arm repeat number two of Aar contain multiple 
residues that could be phosphorylated by GskA. Further peptide synthesis and kinase assays 
would be required to establish whether these are genuine GSK-3 phosphorylation sites. 
3.11.3 Aark phosphorylates Aar in vitro 
The discovery that a kinase other than GskA (named Aark) was able to phosphorylate Aar 
peptides in vitro was unexpected and further characterisation work was performed. 
The charge-separated fraction containing the peak of Aark activity was subjected to further 
FPLC purification. This time separation was performed on the basis of size, and it was 
established that Aark has an apparent molecular weight of 30-35kDa. In addition to 
estimating the size of Aark, the K. value for its interaction with Aar-P1 was calculated to 
be 365µM. This figure may be high compared to other kinase-substrate interactions, but 
several reasons for this could exist. If Aark phosphorylates Aar in vivo, it may be that 
scaffold proteins and/or other additional factors are required. This would bring the kinase 
and substrate into close proximity and reduce the effective Km. Also, the conformation of 
Aar in vivo, compared with that of the Aar peptides, may be such that the phosphate- 
accepting residues are better presented to the kinase. 
Having established the size of Aark and a K. value for its interaction with Aar-P1, the 
focus shifted towards the identification of the kinase. Several approaches were taken. The 
preference for phosphate-primed substrates, and the lack of inhibition by SB-415286, 
suggested that Aark might be Casein Kinase 1. The casein kinase 1 (CK1) family are the 
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only kinase family, other than the GSK-3 family, that are known to show a preference for 
phosphate-primed substrates and some family members are 35kDa. The notion that Aark 
could be CK1 is further enhanced by the finding that CKlct phosphorylates ß-catenin, at 
Ser-45, in vitro (Amit et al., 2002, Liu et al., 2002). 
3.11.4 Is Aark Casein Kinase 1? 
Two parallel approaches were taken to establish whether Aark could be CK1. The CK1 
specific inhibitor CKI-7 was used in an attempt to block Aark activity towards Aar-P1 and 
purified CK1 was used in an attempt to phosphorylate Aar-P1 in vitro. 
The CK1 inhibitor, CKI-7, reduced CK1 activity towards its synthetic peptide substrate 
CKI-P by approximately 80% and reduced Aark activity towards Aar-P1 by 45%. 
However, the manufacturers quote an IC50 value of 9.5µM for CKI-7 interaction with CK1, 
but 80% inhibition was observed with 10µM CKI-7. If the correct IC50 value for CKI-7 
inhibition of CK1 was calculated for these conditions and added to Aark, it may be that 
little inhibition is observed. In other words, the 45% inhibition seen in this assay may have 
been non-specific inhibition associated with the high concentration of inhibitor used. 
Furthermore, purified CK1 failed to phosphorylate either the unprimed (Aar-UP) or primed 
(Aar-P1) peptides in vitro. This suggests that Aark is not to a CK1. However, the CK1 
isoform used in these assays was CK1S, whereas the CK1 isoform that has been shown to 
phosphorylate (3-catenin is CK1a. The two isoforms will phosphorylate some, but not all, 
of the same substrates in vitro. CK18 is the only isoform of CK1 that is commercially 
available, which puts limitations on the experiments. However, only one CK1 has been 
identified in Dictyostelium and this has been shown to have a molecular weight of 49kDa 
(Moreno-Bueno et al., 2000), which is much larger than the apparent size of Aark. 
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The strongest argument against Aark being CK1 comes from an examination of the 
substrate recognition site. A closer inspection of the amino acids that surround the Aark 
recognition site of Aar reveals conservation with the CKI-P peptide. This conservation is 
X-X-G-L, at +1 to the phosphate-accepting serine/threonine residue. However, the Aar-P1 
peptide is terminated after X-X, and therefore an extended Aar peptide containing the 
conserved Gly and Leu residues may be phosphorylated by CK1 in vitro, and CK1 
phosphorylation of Aar could be of in vivo relevance. 
3.11.5 Aark's recognition site 
The recognition site of Aark was determined. Peptides containing single amino acid 
substitutions that produced non-phosphorylatable residues were synthesised commercially. 
The ability of Aark to phosphorylate each of these was tested. Initial results showed that 
two different substitutions abolished Aark phosphorylation. The block caused by one of the 
substitutions could be overcome by increasing the concentration of the peptide and the 
incubation time of the assay. This led to the determination of Aark's phosphorylation site as 
S-X-J-X-T(Phos), with the highlighted Ser residue being the phosphate acceptor. It would 
be interesting to observe the effects of expressing a mutant Aar protein which contains 
amino acid substitutions at this site, and to observe the effects in wild type cells and the aar 
null mutant. 
3.11.6 A GSK-3-like kinase is prgsent in Dictyostelium 
If the evidence presented thus far argues against Aark being GSK-3 or CK1, what is the 
identity of Aark? The gskA null mutant shows no significant activity towards the GSM 
substrate in vitro (Ryves et al., 1998). However, a kinase that shows greatest homology 
with the GSK-3 family has been discovered in the Dictyostelium genomic database. This 
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kinase has been named GLK, for GSK-3-like kinase. An examination of the GLK amino 
acid sequence shows complete conservation of the Arg-96, Arg-180, Lys-205 residues 
which have been shown to be essential for the binding of GSK-3(3 to phosphate-primed 
substrates (Dajani et at., 2001, Harwood, 2001). However, the GLK sequence is not 
conserved at the Axin-binding site of GSK-3ß. It has a Val-267G1y and a Glu-268Arg 
substitution. These exact substitutions have been shown to abolish Axin-binding in GSK-30 
and have multiple effects on GskA in Dictyostelium (Fraser et at., 2002). Aark may be 
GLK, but further analysis is needed. However, if Aark is GLK, then it would be expected to 
phosphorylate Aar in an Axin-independent manner. 
Addition: Both GSK-3 and GskA are unable to phosphorylate Aar at the putative N- 
terminal GSK-3 sites in vitro. This does not preclude that the two proteins do not interact in 
vivo; the protein may be a much better substrate for the kinase than the peptides. 
Alternatively, the phosphorylation of Aar by GskA may require interaction with scaffold 
proteins, for example, or other additional activating factors. However, it may also be that 
Aar is not a substrate for GskA at all. The evidence for a genetic interaction between the 
two proteins has already been established (Grimson et al, 2000; Fraser et al, 2002), but this 
interaction may prove to be indirect. Either way, the interaction would appear to be 
unconventional in comparison with that of GSK-3 and (3-catenin, but this is not unique. The 
interaction between GSK-3 and the (3-catenin homologue WRM-1 in C. elegans, for 
example, is a positive one (see Korswagen 2002), unlike that seen in flies and mammals. 
Further potential GSK-3 phosphorylation sites do exist within the Aar sequence. These sites 
are present within the second armadillo repeat of the protein and align with putative GSK-3 
phosphorylation sites within the second armadillo repeat of ß-catenin (Yost et al, 1996). 
Furthermore, complete loss of the N-terminal GSK-3 sites of ß-catenin does not lead to 
total loss of GSK-3 phosphorylation, suggesting that the protein is indeed phosphorylated at 
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additional sites. Phosphate-primed and unprimed peptides based on the sequence of these 
second sites in Aar have been synthesised. The phosphate-primed and not the unprimed 
peptide has recently been demonstrated to be a substrate for both GSK-3 and GskA in vitro 
(W. J. Ryves, pers. commun. ). It has yet to be established whether an interaction occurs 
between GskA and Aar in vivo, but it would appear that any interaction is unconventional, 
but may turn out to be a universal mechanism for ß-catenin regulation. 
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Chapter 4 
Deletion Analysis of Aardvark 
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4.1 Introduction 
It has previously been established that, like its mammalian counterpart, Aar plays important 
roles in both adhesion and signalling processes within the cell. Aark has been discovered as 
a kinase that will phosphorylate Aar at a defined site in vitro, but is this phosphorylation of 
Aar actually significant to the protein's function? 
In order to answer this question, but also to increase the understanding of the role that Aar 
plays in both adhesion and signalling in Dictyostelium, a series of DNA constructs for the 
expression of Aar and Aar deletion mutants were created. The full-length aar cDNA, or 
deletions encoding N-terminal or C-terminal Aar truncations were cloned into a modified 
version of the pDXA-3C vector (Manstein et al., 1995). The pDXA vector is an 
extrachromosomal, high copy number plasmid, which expresses transgenes from the 
constitutively-expressed actin15 promoter. This vector was previously modified to allow 
for translation from the aar initiator codon (Grimson et al., 2000). 
aar and each of its deletion derivatives were also fused to a sequence encoding a C- 
terminal green fluorescent protein (GFP) `tag' so that the localisation of the proteins could 
be followed in living cells. Figure 4.1 highlights the features of the modified pDXA-3C 
sion vector. 
Actin 15 2,265b 
Actin 8 
promoter terminator 
; ure 4.1 The 9.335Kb pDXA-aar-gfp expression vector 
e 861bp Amp' gene allows for selection in bacteria, whilst the 831bp Neo' gene allows 
positive selection of eukaryotic transformants. The vector also contains a Dietvosteliurn 
gin of replication, for extrachromosomal replication. 
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Aar is required in both a signalling and adhesion capacity within the Dictyostelium cell. 
Thus, multiple phenotypes are associated with the loss of Aar. These include the collapse of 
fruiting bodies and ectopic stalk formation - both associated with the loss of adherens 
junctions; a reduction of pspA gene expression, both during development and in isolated 
cells; and a reduction of spore and stalk cell production in monolayer culture (Coates, 1999; 
Coates et al., 2002; Grimson et al., 2000). 
The two simplest assays were chosen as independent indicators of Aar function. A 
comparison of the morphology of mature fruiting bodies was chosen as a marker for 
adhesion, whilst the expression of the prespore marker gene pspA in isolated cells was 
chosen as a marker for signalling activity. 
4.2 Aar-GFP is functional in the both the aar mutant and wild type Dictyostelium with 
respect to development 
To test that the GFP fusion had no effect on Aar function within the cell, both aar mutant 
and wild type Dictyostelium were transformed with pDXA-aar-gfp. Transformants were 
starved for 24 hours and the morphology of the resulting fruiting bodies examined by light 
microscopy. 
Upon starvation, aar mutant cells will aggregate, but produce fruiting bodies that differ 
from those of wild type cells. Stalks appear thinner and weaker than in wild type structures, 
and the majority of fruiting bodies collapse onto the substratum (Coates, 1999; Grimson et 
al., 2000). These collapsed fruiting bodies are often seen to reculminate from within the 
fallen fruiting body. In addition, aar null mutants form ectopic stalk structures (Coates et 
al., 2002). Over-expression of aar in the aar mutant partially rescues the collapse, but 
fruiting bodies remain weaker than wild type ones (Coates, 1999). 
101 
Transmission electron microscopy (TEM) of cross sections of fruiting bodies of the aar 
mutant revealed a loss of actin fibres at the adherens junctions (Grimson et al., 2000). This 
suggests that Aar is necessary for the formation of Dictyostelium adherens junctions, which 
itself may be a necessary process in the creation of a rigid fruiting body. Conversely, TEM 
of aar mutants over-expressing aar revealed the adherens junctions to possess abnormally 
high levels of actin filaments, leading to a buckling of the membrane. Thus the collapse of 
structures in the aar mutant could be explained by the total absence of adherens junctions, 
whilst the weakness of the aar over-expressing culminants could be explained by an excess 
of adherens junctions. In short, loss or over-expression of Aar upsets the balance of a 
highly regulated adhesion process. 
If over-expression of aar affects fruiting body morphology by causing a disruption to 
regulated cell-cell adhesion, the effect should also occur in wild type cells. This is indeed 
the case. Over-expression of aar in wild type Dictyostelium, causes the stalks of culminants 
to become twisted, leading, in some instances to a collapse of the structures, as seen with 
the aar mutant (Coates, 1999). 
In order to show that the C-terminal GFP fusion does not affect the function of Aar, both 
aar mutant and wild type cells were transformed with the full-length pDXA-aar-gfp 
expression construct. Cells were starved, and allowed to develop on nitrocellulose filters. 
After 24 hours, their morphology was examined by light microscopy. Transforming aar 
mutant cells with pDXA-aar-gfp rescued the collapse of many fruiting bodies, but some 
collapse was also seen (figure 4.2b). Expression in wild type cells led to contortion of the 
stalk tube, smaller spore heads and instability and often collapse of the fruiting body (figure 
4.2d). Both of these observations are consistent with the phenotypes of aar overexpression. 
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Figure 4.2 Cells transformed with pDXA-aar-gfp display the aar 
overexpression phenotype in both aar- and wild type cells 
(a) aar- Dictyostelium. Most culminants have collapsed onto the substratum. 
(b) aar- Dictyostelium overexpressing aar-gfp. Expression of aar-gfp partially 
rescues the collapsed fruting body phenotype but also leaves culminants unstable. 
(c) Wild type Dictyostelium 
(d) Wild type Dictyostelium overexpressing aar-gfp. Note the twisted stalk tubes, 
denoted by the red arrows, and the collapsed fruiting body (blue arrow) in the 
aar overexpressors. Scale bar represents 0.5mm. 
x.:. 
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4.3 Rescue of the aar mutant phenotype by N-terminal and C-terminal Aar-GFP 
deletions 
Each of the deletion constructs were transformed into the aar mutant, and expression was 
determined by northern analysis, utilising an aar cDNA probe (figure 4.3). Maps of the Aar 
deletions are also included in the figure. In addition, western blot analysis was used to 
detect expression of the mutant proteins by way of their C-terminal GFP tags (figure 4.3a). 
Two independent clones of each deletion mutant were starved and allowed to develop on 
nitrocellulose filters. As with the full-length mutants, morphology was examined after 24 
hours by light microscopy. The pictures shown are representative of both clones tested. 
N-terminal deletions: the expression of AN201 Aar-GFP and AN258 Aar-GFP (loss of the 
N-terminus and loss of the N-terminus plus the region containing the Aark phosphorylation 
sites, respectively) led to the same developmental phenotype as expression of full-length 
Aar-GFP (figure 4.4). This suggests that the N-terminus of Aar, up to and including the 
Aark sites, is not required for rescue of the aar fruiting body morphology. However, 
AN371 and AN587 mutants (loss of the putative a-catenin binding site and loss of the first 
7 arm repeats, respectively) resemble the aar mutant (figure 4.4). 
C-terminal deletions: the morphology of all three of the C-terminal deletion mutants of 
Aar resembled the aar mutant (figure 4.5). This suggests that the C-terminus of Aar is not 
essential for developmental rescue. 
The minimum sequence of Aar that will rescue the mutant morphology, from these results, 
is therefore the AN258 mutation 
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Figure 4.3 Detecting expression of Aar-GFP deletions by northern analysis 
(a) Nomenclature of N-terminal and C-terminal Aar-GFP deletions. 
ANxxx = deletion of Aar from the N-terminus as far as amino acid xxx 
ACxxx = deletion of Aar from the C-terminus as far as amino acid xxx 
Black ovals and red star mark the Aark phosphorylation and putative 
a-catenin binding sites, respectively. 
(b) Northern analysis of Aar-GFP deletion mutants, expressed in aar- 
cells. Top panel shows our expression, whilst the bottom panel shows 
the ubiquitously-expressed 1g7 message, shown here as a loading 
control. FL = full-length. 
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(a) 
97 
60 
45 
(b) 
(d) 
Sample Size (kda) 
Positope 53 
aar- N/A 
FL 113 
AN201 90 
AN258 84 
AN371 70 
AN587 46 
AC623 94 
AC288 60 
AC201 52 
(c) 
Figure 4.3a Detection of aar-GFP deletion mutants in cell lysates 
(a) Western blot analysis was used to detect the expression of the Aar-GFP 
deletion mutants in Dictvostelium cell lysates. += positope positive 
control protein; FL = full-length Aar-GFP. 
(b) Coomassie blue staining was used to compare loadings 
(c) The blot in (a) was subjected to a greater period of exposure in order to detect 
bands of weaker intensity. Only the first 6 lanes are shown. 
(d) Table of predicted sizes for each Aar deletion mutant, as determined by 
their amino acid sequences. 
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Figure 4.4 Development of N-terminal Aar-GFP deletion mutants 
Two independent clones of each mutant were developed on nitrocellulose 
filters for 24h. Note that whilst FL, AN201 and AN258 all partially rescue 
the aar- phenotype, AN371 and AN587 mutants display the aar- phenotype. 
Scale bar represents 0.5mm. 
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Figure 4.5 Development of C-terminal Aar-GFP deletion mutants 
Two independent clones of each mutant were developed on nitrocellulose 
filters for 24h. Note that all three mutants display the aar- phenotype. 
Scale bar represents 0.5mm. 
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4.4pspA expression in the Aar-GFP deletion mutants (aar- background) 
The loss of aar leads to both a delay and a reduction in the levels of expression of the pre- 
spore gene pspA during development (Coates, 1999). These observed effects are 
exaggerated in isolated cells (Grimson et al., 2000). Over-expression of aar in the aar 
mutant rescues this reduction, leading to higher levels of expression than in wild type cells. 
The ability of each of the deletion mutants to rescue pspA signalling in the aar mutant was 
examined in isolated cells. Cells were starved by shaking at low density in KK2 buffer for 
6-8h, before shaking with 1mM cAMP for a further 15 hours to induce pspA signalling. The 
experiment was repeated with independent clones and comparable results were obtained. 
N-terminal deletions: loss of the N-terminus of Aar (ON201) had no effect on the ability 
of Aar to rescue the null phenotype (figure 4.6). However, the level of pspA expression in 
the AN258 mutant was close to that of the aar mutant, whilst the AN371 and AN587 
mutants appeared to show reduced levels of pspA expression (figure 4.6b and c). This 
shows the region of Aar containing the Aark phosphorylation sites to be necessary for the 
full rescue of pspA signalling, suggesting a requirement for Aark phosphorylation. 
C-terminal deletions: loss of the final three Arm repeats of Aar (AC623) appeared to 
increase the protein's ability to rescue pspA signalling over and above that of the full-length 
protein (figure 4.6). This suggests that not only is the C-terminus of Aar not required for 
full pspA rescue, but it may actually be inhibitory to Aar signalling function when the 
protein is over-expressed. The AC288 and AC210 mutants showed pspA expression levels 
that were lower than those of the aar mutant, but this will be discussed in section 4.7. 
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Figure 4.6 Northern analysis of pspA expression in aar deletion mutants 
(a) A reminder of the Aar-GFP deletions. 
(b) Northern analysis of pspA expression in aar deletion mutants, expressed 
in an aar- background. Top panel represents pspA expression. The bottom 
panel represents Ig7 expression, included for comparison of loadings. WT 
= wild type; FL = full-length. 
(c) A repeat of the northern analysis in (b), performed with independent clones. 
(d) Table of statistics based upon the densitometry readings for each northern 
(calculated using Quantity One software). Each pspA figure was normalised 
to Ig7 levels, before being expressed as a percentage of FL expression. SD = 
standard deviation. 
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4.5 Development of Aar-GFP deletions in wild type cells 
Each of the deletion constructs were transformed into wild type cells and expression 
determined by northern analysis, probing for aar as in section 4.3 (figure 4.7). 
Two independent clones of each mutant were starved and developed on nitrocellulose 
filters for 24 hours, before examining the morphology of the fruiting bodies. The pictures 
are representative of both clones 
N-terminal deletions: loss of the N-terminus of Aar (AN201) and loss of the Aark 
phosphorylation sites (AN258) still gave the characteristic aar over-expression phenotype 
(figure 4.8). Stalk tubes were twisted, spore heads smaller, and many fruiting bodies 
collapsed onto the substratum. The AN371 and AN587 mutants (loss of the putative a- 
catenin binding site and loss of the first seven arm repeats, respectively) both displayed 
wild type morphology (figure 4.8). These observations are comparible to the results of 
expression of the same deletions in the aar mutant. This suggests that the region of Aar 
between the N-terminus of . N258 and 
AN371 Aar-GFP is important for protein function, 
and. This would be consistent with a-catenin binding at the predicted site. 
C-terminal deletions: wild-type cells over-expressing the C-terminal Aar truncations, 
AC288 & AC210 showed no visible phenotype; that is, development appeared normal in 
comparison with that of wild type cells (figure 4.9). 
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Figure 4.7 Detecting expression of aar deletions by northern analysis 
(a) A reminder of the Aar-GFP deletions 
(b) Northern analysis of Aar-GFP deletions. The top panel represents aar 
expression, whilst the bottom panel represents the 28s rRNA hand (shown 
as a loading control). WT = wild type; FL = full-length. 
Figure 4.8 Development of N-terminal Aar-GFP deletion mutants 
Two independent clones of each mutant were developed on nitrocellulose 
filters for 24h. Note that whilst AN201 and AN258 display the aar over- 
expression phenotype, AN371 and AN587 appear wild type. WT = wild 
type; FL = full-length. Scale bar represents 0.5mm. 
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Figure 4.9 Development of C-terminal Aar-GFP deletion mutants 
Two independent clones of each mutant were developed on nitrocellulose 
filters for 24h. 
OC288 and AC210 developed with wild type 
morphology. WT = wild type; FL = full-length. Scale bar represents 
0.5mm. 
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4.6 pspA expression in the Aar-GFP deletion mutants (wild type background) 
Over-expresssion of aar in isolated wild type cells leads to an increase in the expression of 
pspA (Grimson et al., 2000) 
pspA expression was examined in isolated cells of wild type Dictyostelium expressing the 
Aar-GFP deletions. Cells were shaken at low density as before, and treated with 1 mM 
CAMP to induce pspA expression. The experiment was repeated, using independent clones. 
The results between the two experiments varied; some results were reproducible and others 
were not. These are discussed below. 
N-terminal deletions: the effect of the AN201 and AN258 truncations (deletion of the N- 
terminus and deletion of the Aark phosphorylation sites, respectively) on pspA expression 
differed little from the expression of full-length aar in one northern (figure 4.10c), yet 
showed dominant negative effects in the other (figure 4.10b). The effects of expression of 
AN371 and AN587 however, were more reproducible. The former showed a drastic 
reduction in pspA levels, whilst expression of the latter had little effect in both northerns. 
C-terminal deletions: expression of the AC623 mutants appeared to have little effect on 
pspA levels in both experiments, whilst expression of both the AC288 and AC210 mutants 
caused a drastic reduction in pspA expression levels. 
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(d) 
Value 
Mutant 
blot (b) blot (c) Mean SD 
Ax2 100 100 100 0 
FL N/A 30 N/A N/A 
AN201 3 76 40 52 
AN258 6 159 82 109 
AN371 6 0.5 3 4 
AN587 23 105 64 58 
AC210 10 137 73 96 
AC288 7 -5 1 9 
AC623 3 -0.5 1 3 
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Figure 4.10 Northern analysis of pspA expression in aar deletion mutants 
(a) A reminder of the Aar-GFP deletions. 
(b) Northern analysis of pspA expression in aar deletion mutants, expressed 
in a wild-type background. Top panel represents pspA expression. The bottom 
panel represents the 28s rRNA band, included for comparison of loading. WT 
= wild type; FL = full-length. 
(c) A repeat of the northern analysis in (b), performed with independent clones. 
(d) Table of statistics based upon the densitometry readings for each northern 
(calculated using Quantity One software). Each pspA figure was normalised 
to Ig7 levels, before being expressed as a percentage of wild type expression 
levels. SD = standard deviation. 
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4.7 Discussion 
4.7.1 Aar and cell adhesion 
The expression of N-terminal and C-terminal Aar-GFP deletions affects adhesion and 
signalling processes in both the aar mutant and wild type Dictyostelium. To summarise the 
adhesion effects, table 4.1 lists the morphology of the deletion mutants, whilst table 4.2 
summarises the signalling effects by listing the pspA expression levels. 
Mutant Effect in aar mutant cells Effect in wild type cells 
FL rescue/aar over-expression phenotype aar over-expression phenotype 
AN201 rescue/aar over-expression phenotype aar over-expression phenotype 
AN258 rescue/aar over-expression phenotype aar over-expression phenotype 
AN371 aar-'phenotype wild type 
AN587 aar- phenotype wild type 
AC623 aar- phenotype N/A 
AC288 aar- phenotype wild type 
AC210 aar- phenotype wild type 
Table 4.1 Summary of morphological phenotypes 
The resulting morphology of expression of each deletion mutant in both the aar mutant and 
wild type cells are included. 
Loss of the N-terminus has no effect on the ability of Aar to rescue the aar mutant fruiting 
body morphology, nor its ability to cause the over-expression phenotype. The same is true 
of further deletion to remove the Aark phosphorylation sites. Deletion of the putative a- 
catenin binding sites does, however, affect both of these processes. This supports the idea 
that amino acids 301-331 of Aar contain a binding site for a-catenin. In support of this, a 
vinculin/cx-catenin-like protein has recently been identified in Dictyostelium (T. Soldati, 
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pers. commun). If Aar functions like ß-catenin in the formation of adherens junctions, then 
cadherin binding would be expected in the C-terminus of Aar. Deletion of the final 3 arm 
repeats of Aar created a protein that was unable to rescue the aar mutant, and therefore 
further deletions were also unable to rescue. The last three Arm repeats are therefore 
important for Aar function and it is possible that they could contain a binding site for a 
cadherin-like molecule, although as yet no such protein has been identified in 
Dictyostelium. 
In terms of overexpression phenotypes, deletions with loss of the N-terminus of Aar, 
including the Aark phosphorylation sites, acted like full-length Aar. These results are 
consistent with the aar mutant rescue experiments, which suggest that the N-terminus up to 
and including the Aark phosphorylation sites are not required for Aar's role in adhesion. 
Loss of the putative ct-catenin binding site and further deletion from the N-terminus 
prevented the over-expression phenotype, again supporting the aar mutant data. Deletion of 
the final three Arm repeats caused a phenotype that was partially reminiscent of the 
overexpression phenotype. However, this truncated protein fails to function properly in the 
aar null mutant, suggesting that a different mechanism is acting. The observed phenotype 
may be explained by a reduction in the number of adherens junctions. The truncated protein 
may bind a-catenin, but not a Dictyostelium cadherin. This would mean that it would 
compete with the endogenous Aar protein for a-catenin. But, as it would be unable to bind 
cadherin it would not lead to more recruitment of actin to the adherens junctions, and hence 
this is not an overexpression phenotype. Instead this would prevent the correct formation of 
the adherens junctions through competition for one of the constituent proteins. 
Using these results, a minimum length of the protein that is required for Aar's adhesion 
function can be defined; both from the aar- and wild type data (figure 4.11). 
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Figure 4.11 Summary of the morphology analysis of deletion mutants in both 
aar- and Ax2 backgrounds. 
(a) aar mutant background: schematic of Aar deletions. FL = full-length. The 
shaded region of the protein denotes the minimum length of protein that rescues/ 
gives the over-expression phenotype in the aar mutant, with respect to morphology. 
This is determined by grouping all of deletions that fail to rescue. 
(b) Wild type background: the shaded region of the protein denotes the minimum 
length of the protein that is required to give an aar over-expression phenotype in 
wild type cells, with respect to morphology. The mutants were grouped as in (a). 
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4.7.2 Aar and cell signalling 
A summary of the effects of expression of N-terminal and C-terminal Aar deletions on 
pspA expression in isolated aar mutant cells is listed in table 4.2. 
Mutant pspA in aar mutant cells 
Untransformed Low 
FL High 
AN201 High 
AN258 Low 
AN371 Lower than aar- 
AN587 Lower than aar- 
AC623 Higher than FL 
AC288 Lower than aar- 
AC210 Lower than aar- 
Table 4.2 Summary of pspA expression levels in Aar-GFP deletion mutants 
pspA expression levels in each deletion mutant are summarised in relationship to each 
other, to make them easier to interpret. 
Expression of full-length Aar-GFP increases pspA expression levels in the aar mutant. 
Deletion of the N-terminus (ON201) did not prevent the increase and, in fact, led to greater 
levels of pspA expression. Deletion of the Aark phosphorylation sites (AN258) made a 
protein that was no longer able to rescue pspA expression. Further N-terminal deletions 
(AN371 and AN587), not only failed to rescue pspA signalling, but also reduced levels to 
below those observed with the aar mutant. These dominant negative effects on pspA 
expression, in the absence of Aar, suggest that a second Aar-like protein could be involved, 
or at least partially compensates in the aar mutant. This idea is further supported by the fact 
that pspA expression is not entirely lost in the aar mutant. 
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Figure 4.12 defines the minimum length of the protein that is required for Aar function, 
with respect to pspA expression. This shows that the region of the protein containing the 
Aark phosphorylation sites is required for full pspA expression. This hints that Aark 
phosphorylation of Aar may occur in vivo and, furthermore, may be required for pspA 
expression. 
A reduction in the expression levels of pspA was associated with several of the Aar-GFP 
deletions when expressed in the aar null mutant. This could be an overexpression artefact. 
If Aar were to bind both negative and positive regulators of a the pspA signalling pathway, 
overexpression of certain deletion mutants could sequester out just the negative regulator, 
which would lead to an overload of the pathway. Conversely, the opposite could be true, 
and expression of certain deletion mutants could be leading to inhibition of the pathway by 
way of competing out a co-regulator of pspA expression. This second scenario could be 
explained by involvement of a second Dictyostelium catenin molecule in the pspA 
signalling pathway. In support of this, antisera raised to amino acids 5-304 of human 
plakoglobin recognises a 69 kDa protein in aar- whole cell lysates (Coates, 1999). 
Antiserum raised to the C-terminus of human plakoglobin does not cross-react with this 
protein, named DdPlako. In wild type cells, Aar may be the sole GskA downstream target 
in the pspA signalling pathway of wild type cells but, in the absence of Aar, a DdPlako 
could replace Aar in the pspA signalling pathway. Such cross-talk would not be unique to 
the Dictyostelium pathway. The functions of (3-catenin and plakoglobin are not mutually 
exclusive. As examples, over-expression of plakoglobin induces axes duplication in 
Xenopus (Karnovsky and Klymkowsky, 1995) whilst ß-catenin localises to the 
desmosomes in plakoglobin null-mutant mice (Bierkamp et al., 1999). 
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Figure 4.12 Summary of the pspA northern analysis of aar deletion mutants in 
the aar mutant background. 
(a) Schematic of Aar deletions. FL = full-length. The shaded region of the 
protein is the minimum length required for full rescue of pspA signalling in the aar 
null mutant. The minimum length was determined by overlapping the mimum 
N-terminal deletion that still gives full rescue, with the minimum C-terminal 
deletion that still gives full rescue. As the AC210 mutant showed higher levels of 
pspA expression than the full-length protein, the last 3 Arm repeats were deemed to 
be in some way inhibitory. (The data for Ax2 mutants is excluded from this analysis, 
as results were not sufficiently reproducible). 
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Evidence for cross-talk already exists in Dictyostelium also. Firstly, the over-expression of 
Aar partially rescues the gskA null morphological phenotype, via a reduction of ecrB 
expression (Coates, 1999). Normally, Aar doesn't affect ecmB expression or stalk cell fate. 
aar expression peaks in the latter stages of development, whereas the GskA-mediated 
prestalkB: prespore cell fate decision is made much earlier, at the mound stage (Harwood et 
al., 1995). This suggests that the involvement of Aar in the GskA/prestalkB pathway is an 
over-expression artefact. Secondly, the over-expression of GskA in the aar mutant does 
not rescue the pspA signalling defect (Grimson et al., 2000), but over-expression of an 
Axin-binding mutant of GskA (GskA G/R) does (Fraser et al., 2002). One possibility is that 
GskA could lie downstream of Aar in the pspA signalling pathway, but given all the 
evidence that seems unlikely. No Axin-like protein has been discovered in Dictyostelium to 
date, but the fact that there is a phenotype associated with the expression of GskA G/R in 
Dictyostelium, it seems attractive to think that one may exist. Loss of binding to an Axin- 
like protein could allow GskA to interact with other substrates, which could include 
DdPlako. 
Aark phosphorylation of Aar could be required for Aar binding to this possible Axin-like 
protein. GskA phosphorylation could then be required for activation of Aar. In this 
hypothesis, binding of cAMP to the cAR3 receptor may lead to activation of GskA and, in 
a multistep process, GskA and Aark phosphorylation would be required for activation of 
Aar. This activation would promote pspA expression. However, if the interaction between 
fYOMs E((IO S 
GskA and this possible Axin-like protein was lost, then GskA would become re us 
and may activate other factors, which could include DdPlako. 
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Chapter 5 
Overexpression of Aardvark 
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5.1 Introduction 
Aark has been identified as a kinase that phosphorylates Aar at a defined site in vitro. 
Deletion of a short region of Aar that contains the site of Aark phosphorylation creates a 
protein that is no longer able to mediate pspA expression. Further N-terminal and C- 
terminal deletions of Aar have identified regions of the protein that are required for the 
correct morphology of the fruiting body. These sites are assumed to be binding sites that 
mediate the formation of adherens junctions. It was the aim at the outset of this chapter to 
examine the subcellular localisation of full-length Aar, and also its deletions, to further 
investigate the function of these possible interactions. 
5.2 Aar-GFP cannot be visualised in living cells 
As a control, unfused GFP was expressed from the actin 15 promoter in aar mutant cells 
and examined by confocal microscopy. The GFP protein showed a diffuse pattern of 
fluorescence, suggesting no restriction of the GFP protein within the cell. As seen in many 
other cases, there was a slight enrichment in the nucleus (figure 5.1a). In contrast, 
examination of aar- Aar-GFP cells by confocal microscopy showed only background levels 
of fluorescence (figure 5.1b). Fixed wild type cells stained with anti-Aar antisera showed 
that endogenous Aar has a diffuse pattern of staining throughout the cytoplasm (figure 
5.1c). 
Several possible explanations exist to explain why the over-expressed protein cannot be 
detected. One reason could be that the transgene is not expressed. Northern analysis was 
used to address this question (figure 5.1d). Total RNA was isolated from both aar mutant 
cells and aar mutant cells transformed with pDXA-aar-gfp. Aar cDNA was used to probe 
the blot, and demonstrated the prescence of the transgene in transformed cells only. 
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Figure 5.1 Expression of a full-length GFP-tagged version of Aar 
(a) Confocal microscopy image of aar- cells transformed with GFP alone (false- 
coloured green) 
(b) Confocal microscopy image of aar- cells transformed with pDXA-aar-gfp 
(false-coloured green) 
(c) Anti-Aar anti-sera staining of wild type Dictyostelium (false-coloured red) 
The scale bars in (a), (b) and (c) represent 10µm. 
(d) Northern analysis to detect the expression of Aar-GFP. A= aar- cells, 
AG = aar- cells transformed with pDXA-aar-gfp 
Top panel shows aar-gfp expression, whilst the bottom panel shows expression 
of the ubiquitously-expressed Ig7 for comparison of loadings. 
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5.3 Expression of Aar-V5-His 
As the aar-gfp mRNA was present, then it is possible that it was not translated. The use of 
anti-GFP antisera to detect the fusion protein failed due to the high level of non-specificity 
shown by the antisera towards whole cell lysates (data not shown). The GFP sequence of 
pDXA-aar-gfp was removed and replaced with a double tag comprising the V5 epitope and 
6x His residues, making pDXA-aar-V5-his (figure 5.2). The V5 epitope facilitates easy 
detection of the protein, which could be purified via its 6x His tag on immobilised cobalt 
resin (TalonTM, BD Clontech). The presence of this fusion protein in aar mutant cells was 
detected by western analysis. Figure 5.3a shows the presence of Aar-V5-His, present in the 
transformed cell lysate (AV), but absent in the untransformed aar- cell lysate (A). 
Aar-V5-His is predicted to have a molecular weight of 88kDa. However, a second 
methionine residue, i. e., another putative translational start site, exists at the end of the 
additional N-terminal sequence that Aar posseses compared with 
ß-catenin. The western 
blot analysis in figure 5.3 reveals that the cell must translate this additional sequence in 
vivo, as the size of Aar-V5-His appears to be approximately 88kDa. In addition to detecting 
the protein, the ability of Aar-V5-His to induce higher levels of pspA expression was 
demonstrated by northern analysis (figure 5.3b), showing that this fusion protein is 
functional, at least with respect to pspA signalling. 
promoter 
L 
,LU 
JIJ 
V5/His 
tag 
Actin 8 
terminator 
Figure 5.2 The 8.675Kb pDXA-aar-V5-his expression vector 
The 861bp Amp` gene allows for selection in bacteria, whilst the 831hp Neo` gene allows 
for positive selection of eukaryotic transformants. The Dictvostelium origin of replication is 
also present for extrachromosomal expression. 
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Figure 5.3 Expression of pDXA-aar-V5-his in the aar mutant 
(a) Expression of Aar-V5-His can he detected in oar- cells by Urstern blot 
analysis: P= positope positive control protein (53kDa), A= oar- cell lysate, 
AV = aar- Aar-V5-His cell lysate. Aar-V5-His has a predicted moleular 
weight of 88kDa. 
(b) Northern analysis of aar- Aar-V5-His transformants shows that the protein 
is functional, as determined by an increase in ppspA expression. A= oar- cells, 
AV= nur- Aar-V5-His cells. Top panel shows pupA expression. Bottom panel 
shows expression of the ubiquitously-expressed /g7. included for comparison 
of loadings. 
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5.4 Aar-GFP is destabilised within the cell 
Detection of unfused GFP by confocal microscopy demonstrated that the cells can translate 
the message and synthesise the protein. Likewise, the use of the V5-His tag demonstrated 
that the aar sequence can also be translated and the protein synthesised. This makes it very 
unlikely that the Aar-GFP protein is not being synthesised within the cell. 
If Aar-GFP protein is synthesised by the cell, then why could no fluorescence be detected? 
One explanation centres around the intrinsic fluorescence of the GFP protein. The GFP 
molecule is made up of 238 amino acids arranged in one single polypeptide that is non- 
fluorescent. Fluorescence is emitted from an intrinsic chromophore formed by cyclisisation 
and oxidation of three adjacent amino acids (Ser-65, Tyr-66, Gly-67) (Cody et al., 1993). 
From the synthesis of the polypeptide to completion of the final fluorophore takes 
approximately 4 hours at 22°C in vitro (Cody et al., 1993). This presents two ways in which 
Aar-GFP fluorescence could be prevented. Firstly, the correct folding of GFP is of 
paramount importance to its fluorescence. In other words, any attachment to the protein that 
interferes with the protein's folding may either reduce or abolish fluorescence. It may be 
that the Aar-GFP fusion protein folds in such a way as to hinder the cyclisation and 
oxidation of amino acids 65-67 of GFP, thus affecting fluorescence. The successful GFP 
`tagging' of armadillo repeat-containing proteins, however, has been described many times, 
which makes errors in folding an unlikely reason for the lack of fluorescence. 
The second, and more likely scenario is that Aar is under tight post-translational control 
within the cell, such that the turnover of the protein is high. In mammalian cells, ß-catenin 
is targeted for breakdown via the proteasome following GSK-3 phosphorylation. It is only 
upon Wnt stimulation of the cell that ß-catenin is allowed to accumulate and induce 
expression of downstream genes. Aar-GFP may be subject to a similar mechanism of 
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control in Dictyostelium. This would mean that although Aar-GFP is expressed at high 
levels, each individual molecule is not present for a sufficient amount of time to produce 
the fluorophore and hence fluoresce. If this were the case, then western blot analysis should 
detect the protein. However, the poor specificity of the antisera when tested against 
Dictyostelium whole cell lysates made this difficult. 
5.5 Is Aar-GFP under developmental regulation? 
Both aar mutant and wild type cells expressing Aar-GFP were starved and allowed to 
develop for 24 hours. The resulting fruiting bodies were examined by epifluorescence UV 
microscopy. The level of fluorescence in Aar-GFP over-expressing cells was comparable to 
that of untransformed cells (figures 5.4a & c). Fluorescence could however, be detected in 
fruiting bodies of cells transformed with gfp alone (figure 5.4b). This suggests that even if 
Aar-GFP is under developmental regulation, the levels of protein are insufficient to be 
detected by these methods. 
5.6 Expression of Aar-GFP in fbxA- Dictyostelium 
As discussed in chapter 1, following GSK-3 phosphorylation, the F-box protein ßTrcp 
binds ß-catenin, thus targeting it for breakdown via the proteosome. At least one 
Dictyostelium ßTrcp homologue, FbxA, exists. pDXA-aar-gfp (and pDXA-aar-V5-his as a 
positive control) were transformed into Dictyostelium cells null for JbxA. As with the aar 
mutant, Aar-GFP could not be detected by confocal microscopy (figure 5.5b). Northern 
analysis confirmed that the message was present (figure 5.5c). The presence of Aar-V5-his 
was confirmed by western blot analysis (figure 5.5d), which was consistent with the 
findings in the aar mutant. If Aar-GFP is subject to degradation within the cell, it would 
appear that it is via an FbxA-independent mechanism. 
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Figure 5.4 Development of Aar-GFP transformants 
Cells were developed on nitrocellulose filters for 24h, and viewed 
under a UV dissecting microscope. 
(a) Untransformed cells 
(b) Cells transformed with gfp alone 
(c) Cells transformed with pDXA-aar-gfp 
Scale bar represents 0.5mm 
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Figure 5.5 Detection of overexpressed Aar infbxA- cells 
(a) Confocal image ofjbxA- cells transformed with gfp alone 
(b) Confocal image of fbxA- cells transformed with pDXA-aar-gfp 
Scale bars in (a) and (b) represent 10µm 
(c) Northern analysis to detect aar-gfp message, F =JbxA- cells, 
FG =JbxA- cells transformed with pDXA-aar-gfp. Top panel shows aar 
expression, whilst the bottom panel shows levels of the 28s rRNA subunit, 
shown for comparison of loadings. 
(d) Western analysis to detect Aar-V5-his (predicted molecular weight of 
88kDa) in fbxA- cells. P= positope positive control protein (53kDa); 
F =JbxA- cell lysate; FV = fbxA- Aar-V5-his cell lysate. 
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5.7 Inhibition of GskA by treatment with lithium chloride 
If Aar-GFP is broken down within cells, it would appear not to be via the F-box protein 
FbxA. This does not preclude that Aar-GFP is degraded following the binding of another F- 
box protein, as multiple F-box proteins exist in mammals, flies and plants and so more 
would be predicted to exist in Dictyostelium (see Kipreos and Pagano, 2000) 
To address the question of whether GskA activity leads to Aar-GFP degradation, lithium 
chloride (LiCl) treatment was used to inhibit the kinase. aar mutant cells containing either 
GFP alone or Aar-GFP were treated with 10mM lithium chloride and viewed after 30 
minutes by confocal microscopy. 
Treatment of GFP-only transformants caused the cells to become more rounded, and also 
appeared to increase their fluorescence (figure 5.6). However, no difference in fluorescence 
was observed between the treated and untreated Aar-GFP transformants. This would 
suggest that inhibition of GskA does not stabilise Aar-GFP. This is also consistent with 
previous observations that GskA appears to act positively on Aar (Fraser et al., 2002; 
Grimson et al., 2000). On two independent occasions, however, a very small number (less 
than 1: 100) of Aar-GFP fluorescent cells were detected (figure 5.7). The fluorescence 
within these cells was very diffuse, but was absent from a subcellular compartment with the 
appearance of the nucleus. Upon treatment of these cells with lithium chloride the 
fluorescence pattern changed, from diffuse to a more concentrated pattern, in the 
subcellular compartment that appears to be the nucleus. The same effect was not observed 
with sodium chloride controls or with treatment with IMPase inhibitors. This would suggest 
that this effect is due to the inhibition of GskA, and not the alternative LiCI target within 
the cell, which is IMPase. Unfortunately, it was not possible to repeat this experiment 
further, as no fluorescent cells have since been detected. 
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Figure 5.6 Inhibition of GskA by treatment with lithium chloride 
Treatment of aar- cells transformed with pDXA-aar-gfp with 50mM LiCI 
for 30 minutes failed to restore fluorescence. 
(a) aar- GFP only cells - note the increase in roundedness and fluorescence 
after treatment with LiC1. 
(b) aar- Aar-GFP cells 
Scale bar represents IO tm 
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Figure 5.7 Nuclear translocation of Aar-GFP 
Confocal microscopy was used to detect fluorescence of Aar-GFP cells. 
Untreated cells, cells treated with NaCl and cells treated with the IMPase 
inhibitor all showed a diffuse fluorescence pattern, with exclusion from 
what would appear to be the nucleus. Treatment with LiCl, led to the 
translocation of Aar-GFP to the nucleus. Scale bars represent 10µm. 
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5.8 Proteasome inhibition 
The ubiquitin-proteasome pathway is responsible for the degradation of the vast majority of 
both short and long-lived proteins synthesised within the cell. Therefore, if Aar-GFP 
becomes degraded shortly after synthesis, it is highly likely that the proteasome is involved. 
MG-132 is a potent, reversible, cell-permeable proteasome inhibitor (Tsubuki et at., 1996). 
The use of MG-132 to inhibit the proteasome in Dictyostelium has previously been 
described (Pukatzki et al., 2000). If Aar-GFP is degraded via the ubiquitin-proteasome 
pathway, then treatment of transformants with MG-132 would be expected to produce 
fluorescence. 
aar mutant cells transformed with pDXA-aar-gfp were treated with MG- 132 for 6 hours, to 
allow the protein to accumulate and the GFP fluorophore to form. In addition to Aar-GFP 
transformants, GFP only controls were also treated. Cells were viewed after 6 hours by 
confocal microscopy and cell lysates were produced for western blot analysis with anti- 
ubiquitin antisera. Successful inhibition of the proteasome leads to a build up of 
ubiquitinated proteins within the cell, seen as a smear on a western blot. Whilst the 
successful inhibition of the proteasome was observed (figure 5.8c), no fluorescence was 
detected in the Aar-GFP transformants (figure 5.8b). This would suggest that the sequence 
of Aar responsible for preventing fluorescence - the `destabilisation motif' - leads to a 
conformation of the fusion protein that prevents the production of the GFP fluorophore. 
Alternatively, this sequence contains a degradation motif, responsible for targetting Aar- 
GFP for breakdown independently of the ubiquitin-proteasome pathway. 
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Figure 5.8 Treatment of cells with the proteasome inhibitor MG-132 
Confocal microscopy was used to detect Aar-GFP 
(a) aar- cells transformed with GFP alone 
(b) aar- cells transformed with pDXA-aar-gfp 
Scale bar represents 10µM 
(c) MG- 132-treated aar- Aar-GFP cell lysates, probed with anti-ubiquitin 
antibody. -= untreated, += treated for 6h with 100µM MG-132 
(d) Coomassie blue staining of a duplicate of the gel used in (c), to 
demonstrate equal loading. 
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5.9 Aar-GFP deletions in aar mutant cells 
Direct evidence for Aar-GFP destabilisation remains elusive. However, if this is an active 
mechanism, it should be possible to identify a part of Aar that is responsible for protein 
destabilisation. To test this, confocal microscopy was used to examine the N-terminal and 
C-terminal Aar deletions (see chapter 4) at the subcellular level. Deletion mutants in both 
aar mutant and wild type backgrounds were examined. 
N-terminal deletions: in aar mutant cells, no fluorescence was detectable with the AN201, 
AN258 and AN371 mutants (loss of the N-terminus, loss of the Aark phosphorylation sites 
and loss of the putative a-catenin binding site, respectively) (figure 5.9). However, the 
AN587 mutants (loss of arm repeats 1-7) displayed fluorescence comparable to the levels of 
the GFP-only transformants, which was present throughout the cell. 
C-terminal deletions: whilst the AC623 mutants (deletion of the final 3 arm repeats) failed 
to fluoresce, both the AC288 and AC210 mutants showed high levels of fluorescence 
(figure 5.10), which, again, was present throughout the cell. 
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Figure 5.9 N-terminal deletions of Aar-GFP in the aar mutant 
Confocal microscopy was used to detect fluorescence. The most C-terminal 
fragment of Aar (AN587) displayed GFP fluorescence. GFP = aar- cells 
transformed with gfp alone. FL = aar- cells transformed with full-length 
pDXA-aar-gfp. Scale bars represent 10µm. 
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Figure 5.10 C-terminal deletions of Aar-GFP in the aar mutant 
Confocal microscopy was used to detect fluorescence. Deletion of the 
final 3 arm repeats (AC623) had no effect on fluorescence, but further 
deletion of the C-terminus (AC288 and OC210) led to levels of 
fluorescence comparable with control cells. GFP = aar- cells 
transformed with gfp alone. Scale bars represent 10µm. 
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5.10 Aar-GFP deletions in wild type cells 
The same deletions as used in section 5.9 were also examined in wild type Dictyostelium, to 
see if endogenous Aar has any effect on the localisation of the truncated proteins. As the 
anti-Aar antisera used in figure 5.1c was no longer available, the GFP tags were relied upon 
for further localisation studies. 
N-terminal deletions: as with the aar mutant cells, no fluorescence was detectable in the 
ON201, AN258 and AN371 mutants (loss of the N-terminus, loss of the Aark 
phosphorylation sites and loss of the putative a-catenin binding site, respectively) (figure 
5.11). However, the AN587 mutants (loss of arm repeats 1-7) again displayed fluorescence 
comparable to the levels of the GFP-only transformants. 
C-terminal deletions: whilst the AC623 mutants (deletion of the final 3 arm repeats) failed 
to fluoresce, both the AC288 and AC210 mutants showed high levels of fluorescence 
(figure 5.12). Again, this was consistent with the results seen in the aar mutant. With the 
AC288 mutants, both diffuse cytoplasmic fluorescence and a punctate pattern of 
fluorescence were observed (figure 5.12). 
By aligning the deletion sequences and comparing those which fluoresced, the boundaries 
of the minimum sequence that abolishes Aar-GFP fluorescence was determined (figure 
5.13). This sequence makes up the putative `destabilisation motif' of Aar. 
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Figure 5.11 N-terminal deletions of Aar-GFP in wild type cells 
Confocal microscopy was used to detect fluorescence. The most C-terminal 
fragment of aar (AN587) displayed GFP fluorescence. GFP = car- cells 
transformed with g fp alone. FL = aar- cells transformed with full-length 
pDXA-aar-gfp. Scale bars represent 104m. 
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Figure 5.12 C-terminal deletions of Aar-GFP in wild type cells 
Confocal microscopy was used to detect fluorescence. Deletion of the final 
three arm repeats (AC623) had no effect on fluorescence, but further deletion 
of the C-terminus (AC288 and AC2 10) led to levels of fluorescence comparable 
with control cells. GFP = aar- cells transformed with GFP alone. Scale bars 
represent 10µm. 
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Figure 5.13 Defining the minimum sequence required for Aar destabilisation 
(a) Full-length Aar and each deletion have been aligned. Those that fail to fluoresce 
have been shaded out. This allows the boundaries of the destabilisation sequence to 
be defined (broken red lines). 
(b) Amino acid sequence of the 'destabilisation motif of Aar. 
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5.11 Discussion 
One of the crucial aims of the work presented in this chapter was to express full-length Aar 
protein, with a C-terminal GFP fusion, and examine its subcellular localisation. In trying to 
do this, a putative Aar destabilisation motif was mapped. 
The initial finding that no fluorescence could be detected upon transformation of cells with 
pDXA-aar-gfp, suggested that either the gene or the protein was not present. Northern 
analysis confirmed both the presence of the construct and expression of the gene. In 
addition, the protein was detected by western blot, albeit at low levels. This leaves several 
possible explanations as to why a GFP fusion protein could be expressed, yet fluorescence 
not be detected. Each explanation is individually addressed below. 
" The GFP polypeptide is not being synthesised correctly, i. e. there are mutations in the 
DNA construct which lead to a truncated protein. The entire length of the aar-gfp gene 
was sequenced commercially, and the use of DNA analysis software showed that no 
mutations were present. There is no reason to believe that the sequence of the transgene 
does not correctly encode for an Aar-GFP fusion. 
"A part of the aar-gfp mRNA sequence inhibits its own translation. Several factors argue 
against this being the case. Firstly, the Aar over-expression morphology is observed 
when cells containing pDXA-aar-gfp are allowed to develop. Secondly, the detection of 
Aar-V5-his by western blot and the detection of GFP alone by confocal microscopy 
proves that both the aar and gfp sequences can be translated. There is no reason why 
the combination of aar with gfp should lead to a great reduction in the levels of protein 
that are synthesised within the cell. 
" As the evidence presented so far suggests that Aar-GFP is, in fact, synthesised by the 
ribosomes at the normal rate, then another explanation is that the GFP protein is 
incorrectly folded due to the Aar fusion. The intrinsic fluorescence of GFP relies on the 
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correct folding of the 238 amino acid polypeptide. Following correct folding, three 
adjacent amino acids (Ser-65, Tyr-66, Gly-67) become cyclisised and oxidised to form 
the fluorophore. This process takes up to 4 hours in vitro. The possibility of incorrect 
GFP folding cannot be ruled out from the evidence presented in this chapter. However, 
successful GFP tagging of other arm repeat-containing proteins has previously been 
reported (Giannini et al., 2000; Miller and Moon, 1997; Mimori-Kiyosue et al., 2000; 
Oda and Tsukita, 1999). 
" Degradation of Aar-GFP is the remaining explanation for a lack of fluorescence in 
transformed cells. Several reasons for this may exist. Firstly, the structure of the Arm 
repeats is a-helical. It may be that some of the deletions disrupt the secondary structure 
of Aar in such a way as to compromise the protein's folding. This could lead to the 
protein become degraded. The secondary structure of the protein may possibly not be 
compromised. In which case, either an insufficient level of Aar-GFP within the cell, or 
a turnover rate high enough to leave GFP with insufficient time to fold correctly, would 
prevent fluorescence. 0-catenin is under tight post-translational regulation, targeted for 
breakdown via the proteasome, following GSK-3 phosphorylation and binding of the F- 
box protein, (3Trcp. Expression of Aar-GFP in a strain null for the Dictyostelium F-box 
protein, FbxA, failed to produce fluorescence. Other Dictyostelium F-box proteins may 
exist, and so this method of degradation cannot be ruled out. Inhibition of GskA, the 
Dictyostelium GSK-3 homologue also failed to yield Aar-GFP fluorescence. However, 
some evidence has been presented which suggests that the inhibition of GskA may lead 
to a change in the subcellular localisation of Aar-GFP (see chapter 6 for further 
discussion). 
One unexpected finding was the punctate pattern of fluorescence observed when the AC288 
mutant was expressed in a wild type background. This may be have simply been an over- 
expression artefact. The spots may represent aggregates of the fusion protein, formed due to 
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the high levels of protein within the cell, or they could represent the fusion protein 
localising to the lysosomes, as part of a degradation pathway, again brought about by the 
high levels of protein present within the cell. 
Two plant (3-catenin homologues exist in Arabidopsis thaliana, Arabidillo-1 and 
Arabidillo-2 (for `Arabidopsis Armadillo'). Interestingly, no fluorescence is detected when 
C-terminal GFP fusions of either are over-expressed in Arabidopsis (J. C. Coates, pers. 
commun. ) Both of these proteins contain F-box motifs at their N-terminus. This would 
suggest these proteins do not require binding of an F-box protein to be targeted by the E3 
ubiquitin ligase. On closer inspection of the amino acid sequence, an N-terminal F-box 
domain can also be found in Aar. However, the AN371 truncation lacks the F-box motif, 
yet does not fluoresce. It may be that both the F-box domain and another site are required 
for targetting to the E3 ubiquitin ligase. Whatever the case, elucidation of the mechanism of 
Aar destabilisation should provide further insight into the regulation of this important class 
of molecule. 
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Chapter 6 
Discussion 
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6.1 Aims of work 
It was the aim of this thesis to answer the following questions: 
" Does GskA directly phosphorylate Aar? 
" What physiological roles can be assigned to the various features of the Aar sequence? 
" What does the subcellular localisation of Aar reveal about Aar protein function? 
6.2 Does GskA directly phosphorylate Aar? 
The studies presented in this thesis failed to demonstrate that GskA directly phosphorylates 
Aar. Peptides based upon the putative N-terminal GSK-3 phosphorylation sites of Aar 
turned out not to be substrates for GSK-3 or GskA in vitro. It may be that these sites 
become better substrates when presented to the kinase as part of the whole protein, or it 
may be that other proteins need to be in association in order for GskA to phosphorylate Aar 
in vivo. However, recent evidence suggests that Aar is a substrate for GskA, but that it is 
phosphorylated at alternative sites to those in the N-terminus (W. J. Ryves, unpublished 
data). 
Whilst investigating the phosphorylation of Aar by GskA, a novel, priming-dependent, 
serine/threonine protein kinase, which phosphorylates Aar at the putative N-terminal GSK- 
3 sites in vitro, has been discovered. This kinase was subsequently named Aark, for 
Aardvark kinase. Aark has an apparent molecular weight of 30-35kDa. The K. value for its 
interaction with Aar-P1 was calculated at 365µM. This figure is high, but it may be that 
scaffold proteins and/or other additional factors are required for Aark phosphorylation of 
Aar in vivo. Although Aark phosphorylates Aar in vitro, it cannot be concluded that Aark 
phosphorylates Aar in vivo, and the high Km value does not support this. However, deletion 
of a small region of Aar containing the Aark phosphorylation sites effects the physiological 
function of the protein (see section 6.4). This suggests that Aark phosphorylation may be 
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required for proper Aar function. Creating a knockout of Aark in Dictyostelium would 
provide a simple route to determining this. 
Due to the priming-dependency of Aark, CK1 was a potential candidate. However, CKI did 
not phosphorylate the Aar peptides tested in vitro, and the size of Aark differs greatly from 
that of CK1 isolated from Dictyostelium. A closer examination of the Aar amino acid 
sequence surrounding the Aark recognition site shows conservation with the CK 1 peptide 
substrate CKI-P. This conservation is missing from Aar-P1, suggesting that Aar may be a 
substrate for CK1 in vivo, but that Aar-P1 is not. The phosphorylation site of Aark was 
determined: S-X-S-X-T(Phos), with the Ser residue in bold being the phosphate acceptor. 
This site differs from both the recognition site of GSK-3 and that of CK 1. Therefore Aark 
represents a novel serine/threonine protein kinase, which shows a preference for phosphate- 
primed substrates. 
A GSK-3-like kinase (GLK) has been discovered in the Dictyostelium genomic database 
and shows conservation of the Arg-96, Arg-180, Lys-205 residues which determine the 
priming-dependency of GSK-3 substrates (Dajani et al., 2001; Harwood, 2001). The 
cloning of GLK may provide a short route to the identification of Aark. GLK does not 
show conservation of the Axin-binding domain, so if Aark is GLK, then it would be 
expected to phosphorylate Aar in an Axin-independent manner. It is important to note that 
only circumstantial evidence exists to support the presence of an Axin-like protein in 
Dictyostelium, as none have been discovered to date. 
This work has shown that Aark is able to phosphorylate Aar peptides in vitro. This does not 
mean that Aar is necessarily a substrate for Aark in vivo. Of course, if GLK does turn out to 
in fact be Aark, then it will be relatively simple to determine whether the interaction of 
Aark with Aar is a true one. A simple way to show this would be to take cell extracts of 
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GLK mutants and test them for kinase activity towards Aar in the in vitro kinase assay, as 
in section 3.5 of this thesis. Expression of an Aar protein with mutated Aark 
phosphorylation sites may be expected to exhibit a similar phenotype to the GLK null 
mutant, if Aark is GLK and Aar lies downstream of the latter. 
Another way to investigate whether a physiological role can be assigned to the 
phosphorylation of Aar by Aark, is to express deletion mutants of Aar, some of which lack 
the Aark phosphorylation sites. This approach was taken since it had the added advantage 
of being able to potentially assign functions to other regions of the protein in addition to the 
Aark phosphorylation sites. 
6.3 What physiological roles can be assigned to the various features of the Aar 
sequence? 
A number of N-terminal and C-terminal deletions of Aar-GFP were made and expressed in 
both the aar null mutant and wild type cells. Expression of these truncated proteins was 
determined by both northern and western analyses. The levels of mRNA detected for each 
of the mutants varied considerably, and coincidently some of the higher expressors had 
more drastic phenotypes than the lower expressions. This is coincidental, since the western 
analysis showed that the protein levels did not reflect the mRNA levels detected. It would 
thus appear from this work, that Aar is subject to post-translational control, and that certain 
deletion mutants are able to evade this control (see section 6.4). 
Cell-cell adhesion 
Deletion of the putative a-catenin binding site prevents both the rescue of the aar null 
mutant morphology and the Aar over-expression phenotype. This suggests that this region 
of the protein is important for the adhesive function of Aar. This is consistent with amino 
acids 301-331 of Aar being the binding site for a-catenin and an cc-catenin/vinculin-like 
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protein has recently been cloned in Dictyostelium (T. Soldati, pers. commun). For the role 
of Aar in the formation of adherens junctions to be like that of its mammalian counterpart, a 
site for the binding of the C-terminus of cadherin would also be needed. Deletion of the 
final three Arm repeats of Aar created a protein that was unable to rescue the aar mutant, 
and hence further deletions were also unable to rescue. It could be that the last three Arm 
repeats are required to bind to a cadherin-like molecule, although no such protein has 
identified in Dictyostelium to date. The two sites could be used as bait to identify these 
respective binding proteins in a yeast two-hybrid screen. 
Cell signalling 
Deletion of the region of Aar containing the Aark phosphorylation sites made a protein that 
was no longer able to rescue pspA expression. Further N-terminal deletions not only failed 
to rescue pspA signalling, but also reduced levels to below those observed with the aar 
mutant. Some dominant negative effects were also observed in wild type cells, once the 
Aark phosphorylation sites had been removed from Aar, but these results were unclear. 
Dominant negative effects on pspA expression, in the absence of Aar, suggest that a second 
Aar-like protein could be involved, or at least can partially compensate in the aar mutant. 
This idea is further supported by the fact that pspA expression is not entirely lost in the aar 
mutant. A plakoglobin homologue has been discovered in Dictyostelium, and would be a 
good candidate for this second Aar-like protein. 
As loss of the region of Aar containing the Aark phosphorylation sites prevents Aar rescue 
of pspA signalling in the aar mutant, suggesting that these sites may be required for Aar 
function in vivo. GskA activity is also known to be required for pspA expression, and it 
may be that Aark phosphorylation is required for the GskA-Aar interaction. The second site 
of Aar that was discovered to be important for pspA expression may be required for the 
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binding of Aar to a transcription factor, or maybe a transporter protein, which would direct 
Aar to or from the nucleus. 
To gain a greater insight into what each of the regions of the protein that are now deemed 
important for Aar function, localisation studies were pursued. 
6.4 What does the subcellular localisation of Aar reveal about Aar protein function? 
In order to examine the subcellular localisation of Aar, a C-terminal GFP fusion was added 
to the protein, before expression in both the aar mutant and wild type cells. This work led 
to the observation that Aar may contain a destabilisation motif within its Arm domain. 
Following transformation of cells with pDXA-aar-gfp, no fluorescence could be detected. 
This suggested that either the gene or the protein were absent. Northern analysis confirmed 
both the presence of the DNA construct and expression of the gene, leaving four possible 
explanations as to the lack of fluorescence: 
" Incorrect synthesis of the polypeptide. 
" Failure to translate the mRNA sequence. 
" Incorrect folding of the fusion protein. 
" Degradation of the fusion protein. 
Sequence data showed that there was no reason to believe that the Aar-GFP polypeptide 
was being incorrectly synthesised. An over-expression phenotype was associated with the 
expression of pDXA-aar-gfp, Aar-V5-His could be detected by western blot and 
fluorescence of GFP alone could be detected. This shows that the cell is able to translate 
both the aar and gfp sequences and so there should be no reason why a fusion of the two 
can not be translated. The possibility of incorrect GFP folding cannot be ruled out from the 
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evidence presented in chapter 5, but successful GFP tagging of other Arm repeat-containing 
proteins has previously been reported, suggesting that Aar folding does not affect the 
fluorescence of GFP (Giannini et al., 2000; Miller and Moon, 1997; Mimori-Kiyosue et al., 
2000; Oda and Tsukita, 1999). 
The most probable explanation for the lack of fluorescence associated with Aar-GFP 
transformants is degradation. Either an insufficient level of Aar-GFP within the cell, or a 
turnover rate high enough to leave GFP with insufficient time to fold correctly, would 
prevent fluorescence. This would be analogous to (3-catenin degradation in resting 
mammalian cells, where the F-box protein ßTrcp binds following GSK-3 phosphorylation. 
In the case of Aar, however, there is no evidence for the involvement of a 3Trcp protein or 
proteasome-mediated degradation as yet. 
Treatment of cells with lithium chloride to inhibit GskA failed to induce fluorescence in 
Aar-GFP transformants. However, in a small number of transformants that showed 
fluorescence, the inhibition of GskA led to the redistribution of Aar-GFP within the cell. 
The localisation of the protein changed from a general cytoplasmic distribution to a high 
enrichment in the nucleus. All of the evidence to date suggests that the interaction between 
GskA and Aar is a positive one (Fraser et at., 2002; Grimson et al., 2000). If inhibition of 
GskA causes the accumulation of Aar in the nucleus, then how does GskA function to 
mediate pspA expression? A simple hypothesis would be that Aar functions to export a 
repressor of pspA expression from the nucleus. Nuclear export is also though to regulate the 
repressive function of the C. elegans TCF homologue POP-1 (see Korswagen, 2002). In 
Dictyostelium, GskA phosphorylation of Aar would be required for nuclear export. This is 
consistent with the previous observed role of GSK-3 phosphorylation in the nuclear export 
of cyclin D, NF-AT and DdStatA (Alt et at., 2000; Antos et at., 2002; Ginger et al., 2000). 
In addition, evidence for an Armadillo/Pangolin derepression mechanism required for the 
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expression of Wg target genes in Drosophila has emerged (Chan and Struhl, 2002). This is 
in contrast to the widely accepted belief that upon activation of Wnt signalling, 
Armadillo/(3-catenin enters the nucleus and binds with Pan/TCF transcription factors to 
activate expression of target genes. 
In conclusion, many, but not all, properties of Aar function and regulation are homologous 
to those of ß-catenin in animal cells. Interestingly, upon initial analysis of Aar, its function 
appeared very different from ß-catenin in the canonical pathway. However, it is becoming 
apparent that the current understanding of this pathway may be deficient. The observations 
described in this thesis offer an alternative means to study what could be a universal 
system. 
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